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ABSTRACT OF DISSERTATION 
 
 
 
NONINVASIVE MULTIMODAL DIFFUSE OPTICAL IMAGING  
OF VULNERABLE TISSUE HEMODYNAMICS 
 
Measurement of tissue hemodynamics provides vital information for the 
assessment of tissue viability. This thesis reports three noninvasive near-infrared diffuse 
optical systems for spectroscopic measurements and tomographic imaging of tissue 
hemodynamics in vulnerable tissues with the goal of disease diagnosis and treatment 
monitoring. A hybrid near-infrared spectroscopy/diffuse correlation spectroscopy 
(NIRS/DCS) instrument with a contact fiber-optic probe was developed and utilized for 
simultaneous and continuous monitoring of blood flow (BF), blood oxygenation, and 
oxidative metabolism in exercising gastrocnemius. Results measured by the hybrid 
NIRS/DCS instrument in 37 subjects (mean age: 67 ± 6) indicated that vitamin D 
supplement plus aerobic training improved muscle metabolic function in older 
population. To reduce the interference and potential infection risk on vulnerable tissues 
caused by the contact measurement, a noncontact diffuse correlation 
spectroscopy/tomography (ncDCS/ncDCT) system was then developed. The 
ncDCS/ncDCT system employed optical lenses to project limited numbers of sources and 
detectors on the tissue surface. A motor-driven noncontact probe scanned over a region of 
interest to collect boundary data for three dimensional (3D) tomographic imaging of 
blood flow distribution. The ncDCS was tested for BF measurements in mastectomy skin 
flaps. Nineteen (19) patients underwent mastectomy and implant-based breast 
reconstruction were measured before and immediately after mastectomy. The BF index 
after mastectomy in each patient was normalized to its baseline value before surgery to 
get relative BF (rBF). Since rBF values in the patients with necrosis (n = 4) were 
significantly lower than those without necrosis (n = 15), rBF levels can be used to predict 
mastectomy skin flap necrosis. The ncDCT was tested for 3D imaging of BF distributions 
in chronic wounds of 5 patients. Spatial variations in BF contrasts over the wounded 
tissues were observed, indicating the capability of ncDCT in detecting tissue 
hemodynamic heterogeneities. To improve temporal/spatial resolution and avoid motion 
artifacts due to a long mechanical scanning of ncDCT, an electron-multiplying charge-
coupled device based noncontact speckle contrast diffuse correlation tomography 
(scDCT) was developed. Validation of scDCT was done by imaging both high and low 
BF contrasts in tissue-like phantoms and human forearms. In a wound imaging study 
     
 
using scDCT, significant lower BF values were observed in the burned areas/volumes 
compared to surrounding normal tissues in two patients with burn. One limitation in this 
study was the potential influence of other unknown tissue optical properties such as tissue 
absorption coefficient (µa) on BF measurements. A new algorithm was then developed to 
extract both µa and BF using light intensities and speckle contrasts measured by scDCT at 
multiple source-detector distances. The new algorithm was validated using tissue-like 
liquid phantoms with varied values of µa and BF index. In-vivo validation and 
application of the innovative scDCT technique with the new algorithm is the subject of 
future work. 
 
KEYWORDS: Hybrid Near Infrared Spectroscopy/ Diffuse Correlation Spectroscopy 
(hybrid NIRS/DCS), Speckle Contrast Diffuse Correlation Tomography 
(scDCT), Noncontact Diffuse Correlation Tomography (ncDCT), Muscle, 
Flap, Wound 
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CHAPTER 1. STUDY BACKGROUND AND IMPORTANCE 
 
1.1 Hemodynamic assessment of vulnerable tissues 
Blood flow (BF) facilitates the delivery of nutrients and oxygen to tissues and the 
removal of metabolic byproducts from tissues. BF and its response to physiological 
changes indicate underlying tissue microenvironment conditions. It is equally important 
to understand tissue oxygenation since assessment of tissue oxygenation provides 
important information about the regulation of tissue oxygen delivery. In situations where 
oxygen delivery is insufficient to meet the demand, hypoxia will result. Many diseases in 
biological tissues may be detected by functional imaging of tissue hemodynamics (i.e., 
blood flow and oxygenation) prior to observable or palpable structural changes. Thus, 
monitoring of tissue BF and oxygenation provides critical information to medical 
professionals for the diagnosis and treatment monitoring of various diseases. 
Hemodynamic assessment also serves in animal studies to study pathology of diseases 
and to validate new medications.  
One of the most prevalent objects in hemodynamic study is to characterize the 
hemodynamics in vulnerable tissues for diagnosis and treatment monitoring. 
Specifically, hemodynamic assessment is important for monitoring of vulnerable tissues 
such as wounds or injuries. Monitoring of hemodynamics in wounds (e.g., burn wounds, 
traumatic injuries) provides essential information for determining the necessity and area 
of wound excision and skin grafting to ensure successful surgical outcomes [1]. Notably, 
chronic wounds may never heal or take years to heal, thus resulting in poor quality of life 
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[2]. Individuals with peripheral arterial disease (PAD), diabetes, and paralysis have the 
highest risk of developing chronic wounds [3]. Pressure ulcer has high incident rate in 
patients with spinal cord injury and may lead to pain, infection and sepsis [4]. Prolonged 
pressure that applied to the tissue reducing blood flow and oxygenation supply, together 
with other risk factors including presents of moisture, limited mobility, poor nutrition 
and so on, leads to ulcer and prevents the ulcer from healing [4, 5]. 
 Flap surgery is a common approach for tissue reconstruction. The flap is 
vulnerable and prone to tissue necrosis, which is one the most common complications 
after the surgery [6, 7]. Flap necrosis ensues when the blood supply to the flap is 
insufficient to meet metabolic needs. Knowledge of flap blood perfusion and variation 
during surgery may enable the surgeon to predict necrosis and failure of flaps. For 
example, in this dissertation work, BF in mastectomy skin flap was measured 
intraoperatively for patients undergo mastectomy and implant-based breast 
reconstruction immediately after mastectomy. The results suggested that the decrease in 
BF from pre- to post- operation was highly correlated with the incidence of flap necrosis, 
which demonstrated the potential of intraoperative BF assessment for necrosis 
prediction. 
In many applications, for example in the assessment of intact muscles, contact 
measurement with a probe placed on tissue surface is doable without unforeseen risks. 
Contact measurement ensures better data quality for measurements in exercising 
muscles, which are prevalently used in studying muscle hemodynamics.  However, for 
many other types of vulnerable tissues, such as open wounds and surgery incisions, 
noncontact measurements are preferred over contact measurements, where infection risk 
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and pain induced potentially by applying contact measurements are of great concerns. 
Moreover, the contact pressure applied to tissue surface may result in tissue deformation 
and alter the tissue hemodynamics, and consequently leading to inaccurate measurement 
results. Another benefit of noncontact measurement is that it complies better with sterile 
protocols in operating room for those intraoperative measurements.  
In contrast to spectroscopic measurements, tomographic imaging of vulnerable 
tissue hemodynamics is also desired, as it provides valuable information for determining 
the locations and areas of ischemic/hypoxic tissues. For example, imaging of skin flaps 
may predict the risky area of tissue necrosis. Hemodynamic imaging of wound and 
surrounding tissues facilitates the evaluation of wound healing progress and determines 
the treatment strategy such as the necessity and scope of debridement.   
 
1.2 Technologies for the assessment of tissue hemodynamics 
A wide range of technologies have been developed to measure tissue BF. Doppler 
ultrasound is one of the most commonly used noninvasive techniques [8]. It performs 
well in assessing large vessel blood flow; but deep tissue wounds are more related to 
impairments in microcirculation. Techniques for microvascular perfusion measurement 
include optical coherence tomography [9], photoacoustic tomography [10], optical micro 
angiography [11] and skin perfusion pressure measurement [12]. Most of these 
techniques provide tissue perfusion information at skin level. Fluorescence angiography 
for tissue surface perfusion measurement is invasive and involves intravenous dye 
injection [13-15]. The measurement is transient and does not allow for continuous 
4 
 
monitoring. It has been applied in flap necrosis prediction and has been reported to over 
or under predict the risk of necrosis [15].  
Various types of techniques have been developed for tissue oxygenation 
assessment. Hyperspectral image detects tissue oxygenation at the skin level [16]. 
Oxygen microelectrode can measure cellular oxygen level in a single cell although this 
method is invasive [17]. Transcutaneous oxygen measurement also measures tissue 
oxygenation, but it involves in complicated interaction between different tissue layers 
[18].  
Larger imaging modalities such as positron emission tomography (PET) and 
magnetic resonance imaging (MRI) have the capacity of assessing both tissue 
BF/oxygenation and metabolism [19, 20]. These imaging technologies are expensive 
with large instruments. They require confinement to measurement tubes and thus limit 
the flexibility for muscle function characterization during exercising. In addition, PET 
involves radioactive elements, which is harmful to subjects.  
 
1.3 Diffuse optical technologies for hemodynamic assessment of vulnerable tissues 
Diffuse optical technologies using near-infrared light (NIR, 650-950 nm) have 
become popular over decades because of their noninvasiveness, safety, sensitivity to 
relatively deep tissues (up to several centimeters), and relatively lower cost in contrast to 
other large imaging instruments. These techniques are particularly useful for bedside and 
longitudinal monitoring of deep tissue hemodynamics. A variety of diffuse optical 
technologies have been developed for tissue hemodynamic assessment, including NIR 
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spectroscopy (NIRS) and diffuse optical tomography (DOT) for tissue oxygenation 
measurements [21-23] and diffuse correlation spectroscopy and tomography (DCS/DCT) 
for tissue BF measurements [24-28]. 
NIRS/DOT for tissue oxygenation measurements. NIRS provides a 
noninvasive, low-cost, rapid way for quantification of tissue optical properties, which are 
characterized by absorption coefficient µa (cm
-1
) and reduced scattering coefficient µs’ 
(cm
-1
) [29-31]. The transportation of NIR light in biological tissues is dominated by 
scattering rather than absorption (µs’ >> µa) and therefore can be treated as a diffusive 
process. The absorption spectra of NIR light in biological tissue are shown in Figure 1.1. 
Major tissue chromospheres to absorb NIR light include water (H2O), oxy-hemoglobin 
(HbO2), and deoxy-hemoglobin (Hb). Because of the relatively low absorption in 
biological tissues to NIR light (650 to 950 nm), NIRS can probe deep tissues (up to 
several centimeters). Since NIRS is sensitive to hemoglobin concentration variations in 
microvasculature, it enables tissue blood oxygenation detection, including oxy-
hemoglobin concentration ([HbO2]), deoxy-hemoglobin concentration ([Hb]), total 
hemoglobin concentration (THC), and blood oxygenation saturation (StO2). 
For tomographic imaging with NIRS (i.e., DOT), boundary data measured from 
large numbers of source and detector pairs are used to cover a target tissue volume. 
Three-dimensional images of tissue optical properties and oxygenation can be 
reconstructed from these measured boundary data with DOT principles. DOT has been 
used over decades for tissue oxygenation imaging [21, 22].    
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Figure 1.1 Absorption spectra of hemoglobin and water.  
Tissue absorption coefficients (µa) of the three major absorbers in biological tissues 
(HbO2, Hb and water) are shown as function of wavelengths. Within the NIR window 
(650 to 900 nm), all three absorbers have relatively low absorptions thus enabling NIR 
light to penetrate deep into tissues. HbO2: oxy-hemoglobin, Hb: deoxy-hemoglobin.  
 
DCS/DCT for tissue blood flow measurements. A dynamic NIR technique, 
namely diffuse correlation spectroscopy (DCS), has been developed for blood flow 
measurement in deep tissue [24-28]. Similar to NIRS, DCS uses NIR light to probe deep 
tissues. However, while NIRS only requires laser source with no specific requirement on 
coherence length, DCS uses a long coherence (coherence length > 5 meter) continuous-
wave (CW) laser as the light source and high sensitivity single-photon-counting 
avalanche photodetector (APD) as the detector. DCS detects temporal light intensity 
fluctuations resulting from the interactions between photons and red blood cells in 
microvasculature at a single speckle area on the tissue surface using a single-mode fiber 
that transmits light only directly down the fiber connected to the APD. Through 
quantifying the time scale of light intensity fluctuation, DCS extracts blood flow index 
(BFI) that is related to the motion of red blood cells. Relative changes in blood flow 
NIR 
window 
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(rBF) are subsequently determined by normalizing flow data to its baseline level prior to 
the physiological change. DCS has been extensively validated against other techniques in 
various tissues, including Doppler ultrasound in tumors [32], Xenon-CT in traumatic 
brains, and arterial-spin labeled MRI (ASL-MRI) in human brains and muscles [24, 33, 
34].  
Similar to the extension from NIRS to DOT, DCS has been extended to DCT for 
three dimensional (3D) imaging of BF distributions using boundary data measured from 
multiple source-detector (S-D) pairs on the tissue surface. DCT has been applied for 
preclinical applications in small animal models [22, 35, 36].  
 
1.4 Development and application of innovative diffuse optical technologies for 
hemodynamic assessment of vulnerable tissues 
Conventional NIRS/DOT and DCS/DCT have technical limitations for assessing 
vulnerable tissues in different applications, which are described below. To overcome 
these limitations, I have optimized three innovative NIR diffuse optical systems for 
spectroscopic measurements and tomographic imaging of tissue hemodynamics in 
vulnerable tissues with the goal of disease diagnosis and treatment monitoring. These 
systems include a hybrid NIRS/DCS, a noncontact DCS/DCT (ncDCS/ncDCT), and a 
speckle contrast DCT (scDCT).  
Hybrid NIRS/DCS for hemodynamic characterization of exercising muscles 
in older adults with Vitamin D (vitD) insufficiency (Chapter 2). The conventional 
NIRS or DCS alone is not capable of continuous monitoring of tissue oxidative (i.e., 
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oxygen consumption rate (VO2)) which provides important information for the 
evaluation of muscle metabolic function. One reason for this is that DCS is sensitive to 
the motion of muscle fibers and could get motion artifacts in BF measurements during 
exercise [37]; the other is that DCS can accurately measure the change in BF relative to a 
baseline value, but it is not capable of absolute BF value quantification. 
In this study, we combined a commercial NIRS device with a custom-made 4 
channel DCS (hybrid NIRS/DCS) for simultaneous measurements of BF, blood 
oxygenation, and oxidative metabolism of exercising calf muscles in older adults with 
VitD insufficiency. A contact fiber-optic probe was designed for NIRS/DCS data 
acquisition from the same region of measured tissues. An innovative gating algorithm 
was developed to minimize motion artifacts during exercise [26-28]. Occlusive 
calibration protocols were developed for quantification of absolute VO2 and BF values 
[26-28]. Using the optimized NIRS/DCS technique, I studied the relationships among 
vitD repletion, aerobic exercise, and muscle metabolic function in an older population 
with vitD insufficiency [38]. 
ncDCS/ncDCT for hemodynamic imaging of mastectomy skin flaps and 
chronic wounds (Chapter 3). Conventional NIRS and DCS have been used for 
noninvasive monitoring of oxygenation and blood flow in deep tissues with fiber-optic 
probes that gently contact the skin surface. However, measurements of tissue 
hemodynamics using contact probes are not appropriate for vulnerable tissues, such as 
surgery site and wound tissues. Contact measurement would increase the risk of infection 
and alter the tissue hemodynamic properties by applying the contact probe and thus lead 
to inaccurate measurement results.  
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To reduce the interference and potential infection risk on vulnerable tissues 
caused by the contact measurement, we developed an ncDCS/ncDCT system with optical 
lenses to project sources and detectors on the tissue surface [39-42]. The S-D pairs were 
arranged in a linear array. The motor-driven noncontact probe scanned linearly over a 
selected region of interest (ROI) to collect boundary data for 3D tomographic imaging. A 
finite element method (FEM) based reconstruction algorithm was developed for 3D 
reconstruction of BF distributions from these boundary measurements [39-41].   
I have used the ncDCS/ncDCT system to measure BF distribution in mastectomy 
skin flaps for prediction of skin flap necrosis [43]. An intraoperative protocol for flap BF 
measurement was designed and implemented in 19 patients who underwent mastectomy 
and implant-based breast reconstruction. These patients were measured before and 
immediately after mastectomy, and after breast reconstruction. I have also applied the 
ncDCS/ncDCT system for 3D imaging of BF distributions in 5 patients with chronic 
wounds. 
scDCT for 3D imaging of burn wounds (Chapter 4). The ncDCS/ncDCT 
system enabled noncontact spectroscopic and tomographic measurements of deep tissue 
BF. However, it has poor temporal and spatial resolution due to the time-consuming 
mechanical scanning. Each scanning may take up to more than ten minutes, which is 
prone to motion artifacts. With limited sources and detectors, its spatial resolution was 
poor. The ncDCS/ncDCT system used expensive APDs as detectors, which increase the 
instrument size and cost.  
To overcome these limitations, we developed a camera-based scDCT system [44-
46]. A galvo mirror was used to project point source laser light onto the measured tissue 
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surface. The diffused light speckle pattern was detected by a camera through optical lens 
system. The BF information was extracted from the speckle contrast measured by the 
camera. The scDCT enabled rapid data acquisition with high spatial resolution and 
without mechanical scanning. The optical lens system enabled flexible selection of 
different sizes of ROI for different applications. I used the innovative scDCT system to 
image patients with burned tissues [47].  
One limitation of the scDCT system is the potential influence of unknown tissue 
optical properties such as µa on BFI quantification. Therefore, I developed a new 
algorithm to extract both µa and BFI using light intensities and speckle contrasts 
measured by scDCT at multiple S-D distances. I also designed and conducted tissue-like 
phantom tests to validate this innovative algorithm.  
 
 
 
CHAPTER 2. HYBRID NEAR-INFRARED SPECTROSCOPY/DIFFUSE CORRELATION 
SPECTROSCOPY (NIRS/DCS) FOR ASSESSMENT OF EXERCISING MUSCLE 
HEMODYNAMICS IN OLDER ADULTS WITH VITAMIN D (VITD) INSUFFICIENCY 
 
2.1 Introduction 
Characterization of metabolic function in skeletal muscle has important 
applications in exercise and sports medicine and provides key information for 
understanding many diseases affecting skeletal muscle, such as peripheral vascular 
disease, fibromyalgia and heart failure [48-54]. Understanding of muscle metabolic 
function in older adults is fundamental for understanding the pathology of most age-
related co-morbidities and has the potential to combat muscle function loss and to 
improve life quality.  
Since differences in muscle function between healthy population and population 
with muscle dysfunction are not always apparent at rest, it is important to study muscle 
hemodynamic and metabolic changes in response to stimuli such as rhythmic exercise 
[49, 52, 54-56]. The ability to noninvasively quantify local muscle hemodynamics during 
exercise should provide critical information for muscle metabolic function evaluation, 
and has great potential for improving disease diagnosis and treatment assessment. 
Vitamin D (VitD) and exercise have positive effects on muscle health. Emerging data 
suggest that combining these treatments can alter muscle lipid distribution and 
mitochondrial capacity [57, 58]. This combination may preserve skeletal muscle function 
in aging [58, 59]. Therefore, assessment of muscle hemodynamics during exercise can be 
employed to evaluate muscle performance for older population who receive vitD 
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repletion and/or aerobic training in order to study the relationship between vitD 
repletion, aerobic training and skeletal muscle metabolic function.  
Various techniques have been used in assessment of skeletal muscle blood flow 
(BF) during exercise in previous studies. Doppler ultrasound has been used for this 
purpose but it is limited to large vessel BF assessment. Microvascular BF evaluation 
techniques include laser Doppler flowmetry (LDF) [60, 61], skin perfusion pressure [12], 
and optical coherence tomography [62]; however, these techniques are limited to surface 
BF assessment at skin level. Positron emission tomography (PET) [63] and arterial-spin-
labeled magnetic resonance imaging (ASL-MRI) [64] have made deep tissues 
microvascular BF monitoring possible, but these imaging modalities require large and 
expensive instrumentation that limits their use in exercise monitoring. 
Oxygen consumption (VO2) in skeletal muscle has also been quantified by several 
technologies. Muscle VO2 can be measured invasively using the Fick principle that 
calculates VO2 as the arteriovenous oxygen concentration difference times the cardiac 
output with blood sampling via catheter; however it does not accurately reflect the VO2 
level in local microvasculature because the blood samples are taken from major vessels 
connected to several muscle groups [65]. Spirometry measures whole body VO2 
noninvasively but it does not specify local tissue contribution [66]. Local muscle VO2 
has been quantified noninvasively by phosphorus magnetic resonance spectroscopy (P-
MRS) but requires large and expensive equipment with limited sensitivity, thus limiting 
its application in exercise monitoring [67]. 
Near infrared (NIR) diffuse optical methods for tissue hemodynamics 
quantification have gained popularity in recent years. In previous studies, Near infrared 
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spectroscopy (NIRS) has been applied in investigation of tissue oxygenation changes in 
skeletal muscles during different types of exercise. Another NIR optical technology, 
diffuse correlation spectroscopy (DCS), has been developed for non-invasive 
measurement of the relative change of BF (rBF) in deep tissues [26-28, 32, 34, 68-71], 
including skeletal muscles [26-28, 34, 70]. DCS measurements of tissue BF have been 
validated by other standards, including Doppler ultrasound [56], Xenon-CT [24], and 
ASL-MRI [33].  
Our laboratory has developed a hybrid optical device combining frequency 
domain (FD) NIRS and DCS technologies for simultaneous measurements of oxy and 
de-oxy hemoglobin concentrations ([HbO2], [Hb]), total hemoglobin concentration 
(THC), tissue blood oxygen saturation (StO2), and rBF [72]. Simultaneous measurements 
of rBF and StO2 enable the calculation of relative change in oxygen consumption (rVO2) 
[56]. Only recently, an occlusive calibration has been applied by our lab to allow hybrid 
NIRS/DCS to simultaneously and continuously measure absolute values of BF and VO2 
in skeletal muscle [26, 28]. DCS is highly sensitive to muscle fiber motion and causes 
overestimation of BF during exercise, which prevented it from use in exercise 
monitoring. Recently, an innovative gating algorithm has been developed and applied in 
hybrid NIRS/DCS for exercising muscle monitoring to collect BF data only at time 
points when muscle fiber motion is minimal [26, 28, 37]. The application of the gating 
algorithm significantly improves the accuracy of BF measurements using DCS, and thus 
improved the accuracy in VO2 quantification during exercise using hybrid NIRS/DCS. 
The hybrid NIRS/DCS system has been used in arm muscle measurements during 
exercise in previous studies [26, 27]. However, our particular interests are in the leg 
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muscles because lower limb is more likely influenced by diseases, such as peripheral 
arterial disease (PAD) and muscle metabolic dysfunction [73, 74]. Therefore, we applied 
the hybrid NIRS/DCS system for the hemodynamics monitoring during calf muscle 
exercise [28]. I have validated the hybrid NIRS/DCS system for calf muscle monitoring 
first in young healthy subjects and established the methods for the characterization of 
hemodynamic changes during exercise and in post-exercise recovery [28].  
In this chapter, I report the methods and applications of our innovative hybrid 
NIRS/DCS instrument for quantification of calf muscle hemodynamics during exercise 
in older adults that are given vitD repletion and/or aerobic training to determine the 
effects of vitD repletion and aerobic training on hemodynamic and metabolic functions 
of skeletal muscles. 
 
2.2 Methods 
2.2.1 NIRS for tissue oxygenation  
NIRS theory. The NIR window (650 to 900 nm) has made the application of 
diffuse optical measurements possible for biological tissues. The major chromophores in 
biological tissue are water and hemoglobin (oxyhemoglobin and deoxyhemoglobin). 
Within the NIR window, the absorption coefficient (µa) of water and hemoglobin are 
relatively low, allowing photons to penetrate deeply into tissue to up to several 
centimeters. The photon transportation in biological tissue can be treated as a diffusive 
process because scattering is the dominant event [75, 76]. The scattering coefficient (μ𝑠
′ ) 
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is typically much larger (10 folds) than µa, therefore a photon may have been scattered 
multiple times before it is absorbed and a random walk pattern would be observed.  
The diffusive process of photon propagation in biological tissue can be described 
by the photon diffusion equation [76, 77]. Specifically, the measured photon fluence rate, 
Φ (𝒓,t) [W𝑎𝑡𝑡 ∙ 𝑐𝑚-2 ], obeys the photon diffusion equation written in frequency domain  
as follows [76, 78]:  
∇ ∙ (D(𝒓) ∇Φ(𝒓,𝑡)) – 𝜐 𝜇a (𝒓) Φ(𝒓,𝑡) + 𝜐 𝑆(𝒓,𝑡) = 
∂Φ(𝒓,𝑡) 
∂𝑡 
                         (2.1) 
Where, 𝒓 is the position vector, t [s] is time and 𝜐 [cm ∙ 𝑠 −1] is the speed of light 
in the medium. 𝜇a(𝒓) [𝑐𝑚
-1
 ] is the absorption coefficient, 𝜇s′ (𝒓) [𝑐𝑚
−1
 ] is the reduced 
scattering coefficient, and 𝐷(𝒓) ≡ 𝑣/3(𝜇𝑎 (𝒓) + 𝜇𝑠′(𝒓)) ≈ 𝑣/3µ𝑠′ (𝒓) [𝑐𝑚
2
 ∙ 𝑠-1 ] is the 
photon diffusion coefficient. S(𝒓,𝑡) [𝑊𝑎𝑡𝑡 ∙ 𝑐𝑚−2 ] is the isotropic source term which 
quantifies the number of photons emitted at position 𝒓 and time t per unit volume per 
unit time.  
The right hand side (
∂Φ(𝒓,𝑡) 
∂𝑡 
) describes the rate of the change of photon flunece 
within the sampled volume. It equals the number of photons scattered into the volume 
per unit time from its surroundings (∇ ∙ (D(𝒓) ∇Φ(𝒓,𝑡))), minus the number of photons 
absorbed per unit time within the volume (𝜐 𝜇a (𝒓) Φ(𝒓,𝑡)), plus the number of photons 
emitted per unit time from any sources in the volume (𝜐 𝑆(𝒓,𝑡)). This diffusion 
approximation is valid when the following two premises are met:  𝜇𝑎 ≪ 𝜇𝑠′; the distance 
between source and detector is much greater than the random walk step length (~ 1mm in 
biological tissue) [78].  
When using point source, which can be mathematically described as S(𝒓,𝑡) = 
𝑆0𝛿(𝒓 − 𝒓𝑠)exp(−i𝜔t), where 𝑆0 is a constant, 𝜔 is the modulation frequency of sinusoidal 
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oscillation of the source. and 𝑟𝑠 is the source location, Equation 2.1 can be simplified to 
[79]:  
∇ ∙ ((
𝐷(r)
υ
) ∇Φ(𝒓)) − (𝜇𝑎 (𝒓) + 
iω
υ
 ) Φ(𝒓) = 𝑆0𝛿(𝒓 − 𝒓𝑠 )                             (2.2)  
Where Φ(𝒓,𝑡) = Φ(𝒓)exp(−i𝜔t). 
The analytical solution of Equation 2.2 in semi-infinite geometry is [80]:  
Φ(ρ) = 
v𝑆0
4πD
  ( 
exp(−K𝑟1) 
𝑟1
  − 
exp(−K𝑟2) 
𝑟2
  )                                            (2.3) 
Where 𝐾 2 = 3𝜇𝑠 ′ (− 𝑖𝜔/𝑣 + 𝜇𝑎) , 𝑟1 = √ρ2  +  𝑧0
2  and 𝑟2 = √ρ2  + (𝑧0 + 2𝑧𝑏)2 , 
ρ is the source-detector (S-D) distance, 𝑧𝑏 is the distance above the tissue surface where 
the fluence rate extrapolates to zero and 𝑧0 is the effective depth of the source,  𝑧0 = 1/𝜇𝑠 ′ 
and 𝑧𝑏 = 
2
3μ𝑠
′
1+ 𝑅𝑒𝑓𝑓
1− 𝑅𝑒𝑓𝑓
  , 𝑅𝑒𝑓𝑓 = −1.44𝑛 
−2
 + 0.71𝑛 −1 + 0.668 + 0.064𝑛, 𝑛 ≈ 1.33(for 
biological tissues). The 𝑅𝑒𝑓𝑓 term accounts for the mismatch between the medium and 
the air indices of refraction with 𝑛 being the ratio between them.  
To apply NIRS measurements for tissue absorption and scattering, photodetectors 
are typically used to detect the diffused light at known distances (few millimeters to 
centimeters) from point sources. Figure 2.1 shows a simple measurement setup with one 
pair of source and detector in reflection geometry. Light injected into the tissue from 
source can be detected by the detector placed at a distance ρ from the source location. 
The sensitive region of diffuse light is usually described as a “banana pattern” with the 
penetration depth of ~ρ/2 [78, 81].  
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Figure 2.1 Photon transportation in biological tissues.  
The source and detector fibers are placed on the tissue surface separated by a distance ρ. 
Grey and red dots represent tissue absorbers and scatterers respectively. Multiple 
scattering happen along a single photon path. The green arrows represent the moving 
directions of scatterers. The solid and dashed blue lines indicate potential paths of the 
detected photons. The dashed black lines indicate the potential paths of the photons 
absorbed before reaching to detector. The banana shape area indicates the average path of 
the detected photons emitted from the source location. 
 
Multi-distance measurements of the phase and the amplitude of the photon 
fluence rate Φ(𝒓,𝑡) with FD-NIRS system enable the extraction of optical properties (𝜇𝑠′ 
and 𝜇𝑎) of the measured tissue by fitting the analytical solution (Equation 2.3) with the 
measured fluence rate [82-84]. In the NIR band, deoxyhemoglobin (Hb) and 
oxyhemoglobin (HbO2) have different absorption spectra (Figure 1.1) [85], therefore the 
concentrations of [Hb] and [HbO2] can be calculated from known 𝜇𝑎 at two (or more) 
wavelengths [28, 82, 86]. The measured 𝜇𝑎(λ) at each wavelength can be decomposed 
into the absorption contributions from the major tissue chromophores including Hb, 
HbO2 and water (H2O) [23]:  
μa(λ) = ɛHb(λ)∙[Hb] + ɛHbo2(λ)∙[HbO2] + 𝑃𝐻2𝑂∙ μ𝑎(𝐻2𝑂)(λ)           (2.4) 
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Here, ɛ is wavelength-dependent extinction coefficient of the major tissue 
chromophores. Water absorption is usually considered constant and is thus fixed 
according to literature [87, 88]. Therefore, the two unknowns of [Hb] and [HbO2] can be 
solved with assessment of μa at minimum two wavelengths.  
THC and StO2 can be derived based on [Hb] and [HbO2] consequently as the 
following: THC = [Hb] + [HbO2]; StO2 = [HbO2]/THC × 100%. 
FD-NIRS instrument. In this study a commercial FD-NIRS (Imagent, Iss Inc., 
IL, USA) was used (Figure 2.2). The machine has two banks of sources (eight laser 
diodes at same wavelength for each bank) and one photomultipliers (PMT) detector. The 
2 source wavelengths this machine has are 690 nm and 830 nm. The fiber-optic probe is 
optically coupled to laser-diode sources through multimode fibers (400 um fiber core). 
Sources are distributed at multiple distances (ρ = 2.0, 2.5, 3.0, and 3.5 cm) from the 
detector location. A large fiber bundle (2.5 mm in diameter) connected from the detector 
location on the probe to the PMT is used to detect the scattered light from the tissue. 
Source light at 690 and 830 nm are modulated at 110 MHz and multiplexed so that only 
one laser diode in each bank is on at a time. Fluence rate (AC, DC and phase) are 
measured and used to calculate 𝜇𝑠′ and 𝜇𝑎 for each wavelength and secondary outcomes 
([Hb], [HbO2], etc.).  
Typically, the measurement time for each cycle covering all S-D pairs and 
wavelengths is 150 ms. Data from several cycles may be averaged to improve signal-to-
noise ratio (SNR) upon specific measurement needs. 
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Figure 2.2 FD-NIRS device and probe. 
(a) Commercial FD-NIRS (Imagent, Iss Inc., IL, USA); (b) Schematic of FD-NIRS; (c) 
Probe configuration of Imagent.  FD-NIRS: frequency domain near infrared 
spectroscopy.  
 
2.2.2 DCS for tissue blood flow (BF) 
DCS theory. Similar to NIRS, DCS also probes deep tissues with NIR light. 
Instead of quantifying tissue blood oxygenation from the relatively slow changes in light 
intensities due to tissue absorption and scattering changes, DCS monitors the motion of 
moving scatterers (majorly red blood cells) in tissue by quantifying the fast temporal 
fluctuations in light intensities [36, 78, 89].  
The normalized light intensity temporal autocorrelation function is calculated to 
characterize the light intensity fluctuations at multiple delay time τ:  
𝑔2 (𝒓, 𝜏) = 〈 𝐼 (𝒓,) ∙ (𝒓, + 𝜏)〉/〈𝐼(𝒓,𝑡)〉
2
                                            (2.5)
 
Here, 𝐼 (𝒓,t) is the detected light intensity at position vector 𝒓 (from a source to a 
point of detection) and at time 𝑡. The < > denotes a time average. 𝑔2 is calculated from 
the detected intensity fluctuations of scattered light.  𝜏 represents the delay time of 
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autocorrelation function. 𝑔2 (𝒓, 𝜏) is related to the normalized electric field temporal 
autocorrelation function, 𝑔1(𝜏), through the Siegert relationship [90]: 
 𝑔2 (𝒓, 𝜏) = 1 + 𝛽|𝑔1 (𝒓, 𝜏) |
2 
                                              (2.6) 
Here, 𝛽 is a coherence factor depending mainly on the laser coherence and 
detection optics. 𝛽 can be determined experimentally from measured 𝑔2 (𝒓, 𝜏) via 𝛽 = 𝑔2 
(𝒓, 0) − 1. 
The unnormalized electric field temporal autocorrelation 𝐺1 is defined by   
𝐺1 (𝒓, 𝜏) = 𝑔1 (𝒓, 𝜏) ∙ 𝐺1 (𝒓, 0) = 𝑔1 (𝒓, 𝜏) ∙ I (𝒓, 0)             (2.7) 
The motions contributed by moving scatterers in biological tissue (red blood 
cells) result in the exponential decay of G1. The propagation of G1 in biological tissues 
can be described by the correlation diffusion equation in homogeneous medium for 
continuous-wave (CW)  light source [36, 78, 89]:  
∇ (( 
𝐷(r)
υ
 ) ∇𝐺1 (𝒓, 𝜏)) − (𝜇𝑎 + 
1
3
𝜇𝑠′ 𝑘0
2
 𝛼〈∆𝑟 2 (𝜏)〉) 𝐺1 (𝒓, 𝜏) = − 𝑆0 𝛿(𝒓)         (2.8) 
Here D(𝒓) ≈ 𝑣/3µ𝑠′, 𝑣 is the light speed in the medium, 𝑆0 𝛿(𝒓) is the CW source 
term, 𝑆0 is a constant. 𝑘0 = 2𝜋𝑛⁄𝜆 is the wave number of the source light in biological 
tissue, n = 1.33, 𝜆 is the source light wavelength. 〈∆𝑟2 (𝜏)〉 is the mean-square 
displacement of moving scatterers at delay time τ. To adapt the correlation diffusion 
equation for the use in biological tissues, a unitless factor α (ranging from 0 to 1) is 
introduced here to represent the ratio of light scattering events resulted from “moving” 
scatterers (e.g., red blood cells) to the total scatterers, since some of the scatterers in 
tissue are “static” (e.g., organelles, mitochondria, and nuclei). The factor α is included as 
a pre-fix to 〈∆𝑟 2 (𝜏)〉 (i.e., α〈∆𝑟 2 (𝜏)〉) to indicate the mean square displacement of 
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“moving” scatterers in biological tissues. In a semi-infinite homogeneous medium, 
analytical solution of 𝐺1 (𝒓, 𝜏) are [78]:  
𝐺1 (𝒓, 𝜏) = 
v𝑆0
4πD
  ( 
𝑒−𝐾(𝜏)𝑟1  
𝑟1
  − 
𝑒−𝐾(𝜏)𝑟2  
𝑟2
 )                                           (2.9) 
Consequently, combing with Equation 2.7, the analytical expression for 𝑔1 (𝒓, 𝜏) 
can be derived as:  
𝑔1 (𝒓, 𝜏) = 
G1 (𝒓,τ)  
G1 (𝒓,0)
 = ( 
𝑒−𝐾(𝜏)𝑟1  
𝑟1
 − 
𝑒−𝐾(𝜏)𝑟2  
𝑟2
 ) / ( 
𝑒−𝐾(0)𝑟1  
𝑟1
 − 
𝑒−𝐾(0)𝑟2  
𝑟2
 )                (2.10) 
where 𝐾 2 (𝜏) = 3𝜇𝑠′𝜇𝑎 + 𝜇𝑠′
2
 𝑘0
2𝛼〈∆𝑟2 (𝜏)〉, is an effective “absorption” for the 
attenuation of G1 as it transports through the tissue; while 𝑟1, 𝑟2 and 𝒓 are the same as in 
Equation 2.3. 
For diffusive motion, 𝛼〈∆𝑟2(𝜏)〉 = 6𝛼DB 𝜏, where DB is the effective Brownian 
diffusion coefficient of tissue scatterers [91]. The combined term, 𝛼𝐷B, is referred as the 
blood flow index (BFI) in tissues and its relative change is commonly used to calculate 
the relative change of blood flow (rBF) compared with the baseline/resting BFI.  
By introducing the BFI term 𝛼DB, it is easy to tell that the analytical solution of 
𝑔1(𝒓, 𝜏) is a function of 𝛼DB and tissue optical properties (e.g., 𝜇𝑠′ and 𝜇𝑎). Tissue optical 
properties can be measured using NIRS or assumed from literature, then 𝑔1(𝒓, 𝜏) is solely 
determined by 𝛼DB. Meanwhile, the measured 𝑔1(𝒓, 𝜏)  can be converted from the 
measured 𝑔2(𝒓, 𝜏)  using the Siegert Relation (Equation 2.6) [90].Therefore, 𝛼DB can be 
extracted by varying 𝛼DB in the analytical solution of 𝑔1(𝒓, 𝜏) and fitting it to the 
measured 𝑔1(𝒓, 𝜏) [25-28, 82].  
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DCS instrument. Figure 2.3a shows a 4-channel DCS device used in this study. 
It is consisted of a CW long coherence laser (coherence length > 5 m) at 830 nm (100 
mw, CrystaLaser Inc., NV, USA), 4 single-photon-counting avalanche photodiodes 
(APDs) (e.g., Perkin Elmer Inc., Canada), and an autocorrelator board (Correlator.com, 
NJ, USA).  
 
Figure 2.3 DCS device and probe. 
(a) A 4-channel DCS device; (b) Schematic of DCS; (c) DCS probe. DCS: diffuse 
correlation spectroscopy. 
 
The laser and APDs are connected to tissue surface through optical fibers. A 
fiber-optic probe is usually made with foam pad to confine source and detector fibers 
(Figure 2.3c). The S-D separation along the tissue surface is selected according to the 
specific applications. Same as NIRS, the penetration depth is typically half of the 
distance between source and detector.  
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During a measurement, the laser diode shines the NIR light through a source fiber 
(multi-mode fiber, diameter = 200 µm) into the tissue (Figure 2.3b). The temporal light 
intensity variations caused by the moving scatterers in a single speckle area are detected 
by detector fiber(s) (single-mode fiber, diameter = 5 µm) connected to the APD(s). The 
output of the APD is sent to the autocorrelator board to calculate the normalized light 
intensity temporal autocorrelation function (g2). g2 at each delay time (𝜏) is saved to data 
log and used to extract αDB in post processing (see data processing diagram in Figure 
2.3b).  
 
2.2.3 Hybrid NIRS/DCS 
In order to measure blood flow and oxygenation simultaneously, our lab built the 
hybrid NIRS/DCS. Figure 2.4 shows the picture and diagram of the hybrid NIRS/DCS 
instrument [26-28, 71]. Computer-controlled TTL signals were used to trigger the 
Imagent and DCS devices working sequentially. A 50 ms delay between the transition of 
Imagent and DCS measurements was set to avoid the potential interference between the 
two devices. The hybrid fiber-optic probe was modified based on the commercial 
Imagent probe (Figure 2.5) by housing the DCS source and detector fibers into the 
Imagent probe. The optical fibers for the DCS measurement were arranged in the pattern 
shown in Figure 2.5 for minimal interference between DCS and NIRS measurements, 
and for flexible selection of S-D separation for blood flow measurement (1.5 cm to 2.5 
cm). Acquisition times for NIRS and DCS measurements can also be varied based on the 
needs for specific applications.  
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In addition to simultaneous measurements of BF and tissue oxygenation, the 
hybrid NIRS/DCS allows for calculation of rVO2: rVO2 = (100 - StO2)/(100 - resting 
StO2) × rBF, which is a critical parameter for assessment of tissue viability. 
 
Figure 2.4 hybrid NIRS/DCS device. 
The hybrid NIRS/DCS consists of a commercial FD-NIRS (Imagent, right) and a 4-
channel DCS flowmeter (left). The Imagent and DCS work alternatively and 
communicate with each other through TTL signals.   NIRS: near infrared spectroscopy, 
DCS: diffuse correlation spectroscopy, FD: frequency domain.  
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Figure 2.5 Fiber-optic probe for hybrid NIRS/DCS device. 
The hybrid probe is made based on the commercial Imagent probe by inserting DCS 
source and detector fibers into the probe. Several slots have been created for flexible 
selection of source-detector separation(s) for DCS measurement. NIRS: near infrared 
spectroscopy, DCS: diffuse correlation spectroscopy. 
 
2.2.4 Occlusive calibrations for absolute oxygen consumption rate (VO2) and BF 
Each subject was placed in sitting position with the right foot secured to a 
dynamometer (Primus, BTE, Hanover, MD) foot plate (Figure 2.7). The fiber-optic 
probe for NIRS/DCS was attached to the belly of the calf muscle. A pressure/occlusion 
cuff (Zimmer ATS 1000, Indiana) was affixed to the thigh of the right leg. The optical 
probe was then secured to the medial gastrocnemius. Then a series of occlusion were 
completed. The protocol is illustrated in Figure 2.8 (a). A 3-min baseline period was 
recorded by the hybrid NIRS/DCS to ensure hemodynamic stability. After the baseline 
measurement, three venous occlusions (VO) (50 mm Hg tourniquet pressure for 10 s) 
were performed, each with 1 min in between to allow tissue hemodynamics return to 
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rest. Upon completion of the three VOs, a single arterial occlusion (AO) (∼250 mmHg) 
was performed for 3 min. Subject recovery was monitored following the AO for 5 min. 
 
Figure 2.6 Hybrid NIRS/DCS measurements of exercising gastrocnemius with 
occlusive calibrations and gating algorithms. 
 
Baseline absolute BF was obtained by fitting the slope of the THC increase 
measured by NIRS during VO (Figure 2.7 (b)) [27, 73]. The three slopes were then 
averaged as the absolute BF. Baseline absolute VO2 was calculated by fitting the slope of 
the difference between [HbO2] and [Hb] during the first minute of AO (Figure 2.7 (c)) 
[26, 92]. 
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Finally, the time-course rBF and rVO2 data were calibrated to absolute BF and 
VO2 by multiplying the absolute baseline BF and absolute baseline VO2 obtained 
through the VO and AO protocols, respectively. 
 
Figure 2.7 Occlusive calibrations for absolute BF and VO2. 
(a) Protocol illustration. (b) THC slope during VO was used to calculate baseline BF. (c) 
[HbO2] – [Hb] slope during AO was used to calculate baseline VO2. THC: total 
hemoglobin concentration, [HbO2]: oxy-hemoglobin concentration, [Hb]: deoxy-
hemoglobin concentration, VO: venous occlusion, AO: arterial occlusion,  
 
2.2.5 Gating algorithm  
The gating algorithm was designed to reduce the influence of muscle fiber motion 
on DCS measurements [27, 28, 37]. The logic of the gating algorithm is illustrated in 
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Figure 2.8. The algorithm determines muscle contraction status during plantar flexion 
based on an analog voltage output of foot pedal position from dynamometer (blue curve 
in Figure 2.8). The analog voltage output decreased with foot/pedal position changes 
during plantar flexion and increased back when the foot/pedal was bouncing back to 
resting position.  
 
 
Figure 2.8 Illustration of gating algorithm. 
The blue curve represents the signal from dynamometer voltage output, indicating foot 
pedal position. Red marks in each cycle illustrate triggers determined by a threshold. The 
hybrid NIRS/DCS collects data during muscle relaxation (inside the black square) 
between contractions.  
 
Each time the voltage surpasses a threshold when the foot/pedal bounced back 
indicating muscle status changing from contracted status (low voltage) to relaxed status 
(higher voltage plateau), a trigger signal will be sent to DCS. After a short delay (50 ms) 
to allow for residual motion, DCS then begins recording data. After DCS finishes data 
collection, NIRS will be triggered to collect data. After a complete frame had been 
collected by the hybrid NIRS/DCS, the algorithm waits for the next rising edge in the 
position signal to trigger the next data collection sequence. Thus, DCS sampling window 
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is constrained to the rest period between each cycle of muscle contraction during 
exercise period. In this study, DCS sampling time was about 600 ms, and NIRS sampling 
time was about 300 ms, together with some communication time in between, the total 
sampling time for each frame of the hybrid NIRS/DCS was around 1 second.  
 
 
2.2.6 Fatigue gastrocnemius plantar flexion protocol 
Subjects were seated on a dynamometer (BTE Primus RS, Maryland) with the 
calf exposed for easy placement of the fiber-optic probe of NIRS/DCS (Figure 2.6) [26, 
28]. The right foot was placed and secured in the plantar-flexion attachment. Following a 
warm up to familiarize the subject with the plantar flexion movement, maximal 
voluntary isometric contractions (MVC) were completed to determine the maximum 
torque generation. The highest concentric plantar-flexion peak-torque value is recorded 
as the final MVC. After MVC test, the fiber-optic probe for NIRS/DCS was attached to 
the belly of the calf muscle. Gastrocnemius hemodynamics, including blood flow (BF), 
blood oxygen saturation (StO2), and oxygen consumption rate (VO2), were then 
continuously monitored before, during and after the fatigue exercise [26, 28]. Three 
minutes of resting status data was first taken prior to the start of fatigue exercise. During 
the fatigue exercise, subjects were asked to complete 75 repetitions of isotonic concentric 
plantar-flexion contractions at maximal voluntary angular velocity with torque set to 
35% of MVC. During the exercise, the previously described gating algorithm (Chapter 
2.2.5) was used to automatically collect hemodynamic data at an eccentric phase pause 
(by reading foot pedal angular position) prior to every plantar-flexion contraction to 
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reduce the motion artifact. Foot pedal position and torque were also continuously 
recorded during the exercise (Chapter 2.5.1). After completion of the exercise, 15 
minutes recovery was recorded.  
Gastrocnemius BFI was extracted from DCS data. For this study, S-D separation 
for DCS was set at 2.5 cm (Figure 2.5) so that the detected signal would be primarily 
from skeletal muscle layer rather than subcutaneous adipose tissue. A 4-in-1 detector 
fiber was used that four fiber cores were integrated together on one end and were 
plugged at the same location (4 different single speckle areas that were ~ 5 µm apart 
from each other) in the probe, while the other end of each fiber were connected to one of 
the four APDs. Therefore, in the post processing, a spatial average was used to average 
DCS data from the 4 channels at the same time frame to increase the SNR before 
extracting 𝛼DB.  
StO2 was calculated from NIRS data at multiple separations (2.0–3.5 cm). rBF 
was calculated by normalizing BFI at all time frames to the averaged BFI (assigning 
100%) during the last 2 min prior to the exercise [28]. Resting StO2 was calculated as an 
average of StO2 during the last 2 min prior to exercise. ΔStO2 was calculated as the 
increase of StO2 at all measurement times from resting StO2 to minimize the influence of 
individual variation in resting StO2 and to enhance the StO2 response induced by the 
fatigue exercise. The rVO2 was calculated as rVO2 = (100 - StO2)/(100 - resting StO2) × 
rBF. Recovery half-time (T50) of rVO2 was calculated as the time interval from the end 
of exercise to the time that they reached a half-maximal value to characterize post-
fatigue exercise recovery [27]. 
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2.2.7 Monitoring of muscle hemodynamics during fatigue gastrocnemius plantar 
flexion in older adults with vitD insufficiency 
This was a 13-week double blinded placebo, controlled study. The experimental 
protocol was approved by the University of Kentucky (UK) Institutional Review Board 
(IRB). Subjects in normal weight to class I obese (body mass index = 18.5 to 34.9 kg/m
2
) 
between 60 to 80 year-old and with vitD insufficiency (25(OH)D ≤ 32 ng/mL) were 
recruited. Subjects who passed the screening were randomized into one of the 4 group 
assignments: vitD repletion + aerobic training (DAT), aerobic training (AT), vitD 
repletion alone (D) and control (CTL).  
Before (week 0) and after (week 13) the intervention, muscle hemodynamics 
during fatigue exercise was measured using the hybrid NIRS/DCS for each subject. The 
occlusive calibration was first done to quantify baseline BF and VO2 with the method 
introduced in Chapter 2.2.4. Then gastrocnemius hemodynamics during fatigue plantar 
flexion protocol (Chapter 2.2.6) was measured. rBF, rVO2, StO2, ΔStO2 and T50 of 
rVO2 were calculated as introduced in Chapter 2.2.6.  
ANOVA and paired t-tests were used to evaluate the intervention effects. Values 
were presented as mean ± standard error of mean (SEM).  
 
2.3 Results 
Thirty-seven subjects completed the intervention and participated in both baseline 
(week 0) and endpoint (week 13) measurements. Figure 2.9 shows a typical 
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hemodynamic responses profile in rBF, rVO2, and StO2 in subjects during fatiguing 
exercise.  
 
Figure 2.9 Typical muscle hemodynamic responses to exercise. 
Representative profile of (a) blood oxygen saturation (StO2), (b) relative blood flow 
(rBF), and (c) relative oxygen consumption rate (rVO2) in a subject throughout the 
fatiguing exercise. Solid vertical lines indicate the beginning and the end of fatiguing 
exercise. Half recovery time (T50) definition is demonstrated in (c).  
 
At baseline prior to the intervention, there were no differences in blood flow 
during the fatiguing exercise protocol between groups; however endpoint comparisons 
showed significant group differences (p = 0.04, ANOVA) (Figure 2.10(a)). DAT had 
significant higher blood flow during exercise than CTL (p = 0.01) and AT (p = 0.01). 
Similar trend were found in rVO2 during exercise. rVO2 during exercise of DAT was 
significantly higher at endpoint than CTL (p = 0.007), AT (p = 0.002), and D (p = 0.013, 
ANOVA) (Figure 2.10(b)). No significant differences in StO2 were found between 
intervention groups during exercise at baseline or endpoint.  
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Upon finishing the fatiguing exercise, hemodynamic variables began to return 
towards their pre-exercise levels: rVO2 and rBF decreased during recovery, and StO2 
increased during recovery. Throughout the 15 minutes of recovery, there were no 
significant differences in rBF, rVO2, or StO2 by time or by group (p>0.05, 
RMANOVA).  To further explore the intervention effects on StO2 we examined shifts in 
StO2 from baseline to endpoint for each minute of recovery (minutes 1-15).  Within 
group comparisons showed that DAT was the only group had significant reduce in 
StO2 towards full recovery from baseline to endpoint (Figure 2.11(a)). The observed 
DAT group trends became stronger from minutes 1 to 6 in recovery phase. Significance 
was attained (p<0.05, paired t-test) at minute seven and continued throughout the rest of 
recovery. Statistical differences are represented by an average of StO2 during the final 
minute of recovery (Figure 2.11(b)).  
 
 
Figure 2.10 Hemodynamic responses to 13 weeks of intervention. 
(a) Endpoint (week 13) relative blood flow (rBF) during exercise by group (AT: aerobic 
training; CTL: control; D: vitamin D; DAT: vitamin D + aerobic training). (b) Endpoint 
(week 13) relative oxygen consumption rate (rVO2) during exercise by group. (c) 
Recovery half-time (T50) of rVO2 at study baseline (week 0) and endpoint. Bars 
represent mean ± SEM. 
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Figure 2.11 Muscle blood oxygen saturation responses to 13 weeks of intervention in 
post-exercise recovery. 
(a) Change in oxygen saturation (ΔStO2) by group at study baseline (week0) and endpoint 
(week 13) in post-exercise recovery (AT: aerobic training; CTL: control; D: vitamin D; 
DAT: vitamin D + aerobic training). (b) DAT: group average of ΔStO2 at baseline and 
endpoint during and post exercise. Bars represent mean ± SEM.  
 
For rVO2 T50, paired t-tests showed a significant decrease in only DAT (-28.7 ± 
31.3 seconds, p=0.03) (Figure 2.10(c)). However, there were no differences among 
groups in StO2 T50 (p>0.05). Due to rapid change, the recovery half time of blood flow 
was not calculated.  
Lastly, no significant changes in torque or in absolute BF, absolute VO2 were 
observed. 
 
2.4 Discussion and conclusions 
We have developed a hybrid NIRS/DCS system for simultaneous and continuous 
monitoring of tissue oxygenation and BF. Simultaneous measurements of NIRS and 
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DCS enable quantification of skeletal muscle rVO2. The novel occlusive calibration 
techniques and the gated dynamometer exercise protocol that have been previously 
applied on forearms have been tailored to the lower limb for the first time in this study 
[26-28, 93]. Occlusive calibrations make it possible to quantify absolute values of BF 
and VO2. We also developed an exercise protocol for lower limb that is comparable in 
duration and intensity to other studies and could be done by both healthy subjects and 
PAD patients [28]. Innovative gating algorithms significantly reduce motion artifacts and 
improve the accuracy of BF measurements during exercise. The removal of these 
artifacts means that DCS can produce rapid, continuous examination of microvascular 
muscle BF during exercise, which is a unique functionality of the system.  
We have successfully applied the hybrid NIRS/DCS for the characterization of 
muscle hemodynamics during and post gastrocnemius fatiguing exercise in an older 
healthy active population with vitD insufficiency. The DAT intervention had significant 
effects on rBF, StO2, and rVO2 T50. We examined shifts in StO2 from study baseline 
to end study to better represent StO2 response to exercise. DAT was the only group that 
had significant decrease in StO2 during the recovery (min 7-15). A reduction in StO2 
indicates an enriched mitochondrial capacity by increasing oxygen extraction to muscles 
[27]. DAT was the only group experienced a significant decline in rVO2 T50 over time 
(baseline to endpoint), which could be attributed to a beneficial alteration of muscle 
oxygen utilization, suggesting improved mitochondrial function. Together, these changes 
in hemodynamics and oxygen consumption may be attributed to multiple mechanisms 
including improved muscle blood flow and oxygen delivery creating a reduction in 
36 
 
oxygen debt, improved lipid substrate availability to the mitochondria, and direct 
improvements of mitochondrial function [94].  
In summary, NIRS/DCS data show increased rVO2 and rBF in response to 
fatiguing exercise and faster recovery after exercise in subjects receiving DAT. This 
suggests that combining aerobic exercise with vitD repletion may help improve muscle 
metabolic function. The hybrid NIRS/DCS instrument effectively measures muscle 
hemodynamic and metabolic changes during and after exercise, and has potential for 
continued high impact in translational studies combining techniques to comprehensively 
understand skeletal muscle function. 
 
2.5 APPENDIX: Other engineering work  
2.5.1 Torque and position data acquisition 
As mentioned in Chapter 2.2.6, torque and foot pedal position were recorded 
during exercise. Torque and position were provided by the dynamometer as analog 
outputs (voltage, 0 to 3.3 V). An Arduino based data acquisition system was built to 
monitor and save the data.  
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Figure 2.12 Torque and position data acquisition system. 
The system is composed of Arduino Uno board, micro secure digital (SD) card module, 
LCD module and a mode selection switch. Cable connections with dynamometer are 
marked: Uno analog input channel 1 (A1) and channel 2 (A2) are connected to 
dynamometer analog output channels of position signal (P) and torque signal (T). The 
ground (GND) of dynamometer and Uno are also connected.  
 
The system composition and cable connection are shown in figure 2.12. Arduino 
Uno was selected for this project to cover all the needs. Analog input channel 1 and 2 of 
Uno were employed to record position and torque signal respectively. A liquid crystal 
display (LCD) screen was connected with Uno for data monitoring in real time.  A mode 
selection design was realized by a switch to select “monitor only” or “monitor and save” 
mode. A micro secure digital (SD) card module was integrated into the system to save 
the data.  
Uno was programmed to realize the following function. When the system was 
powered, Uno first checked the status of the micro SD card, an error message would pop 
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out on LCD if the micro SD card was not in place. After initialization, the LCD 
displayed the real time torque and position data in number, refreshed at 20 Hz. Data 
saving started when the switch was pushed to “monitor and save” mode; A new txt file 
was created at the same time in the micro SD card and Uno wrote torque and position 
data in 2 separated columns into the file at 20 Hz until the switch was pushed back to 
“monitor only”.   
 
2.5.2 Automatic recognition of torque peak  
Torque peak of each plantar flexion cycle during the exercise were calculated as a 
secondary outcome of the measurement. An automatic torque peak recognition algorithm 
with a graphical user interface (GUI) was developed using MATLAB to improve the 
accuracy and free the labor form manual recognition and data logging.  
The algorithm first converted the raw voltage signal of position and torque 
collected with the above-mentioned system into meaningful values with correct units 
after importing the raw data file. Then the 75 cycles were segmented using position 
signal because position had more regular periodic pattern comparing with torque signal. 
The torque peak value within each cycle was then calculated. The GUI displayed time 
sequence of torque signal during exercise with torque peaks marked (Figure 2.13) and 
allowed minor manual corrections (optional) by adding or removing torque peak points. 
A cursor was provided to select the point to add/remove. The selection did not need to be 
exact: the algorithm would allocate the nearest cycle/target to process. After finalizing all 
torque peaks, results were saved to a txt file with assigned file name through the GUI.  
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Figure 2.13 Graphical user interface (GUI) for automatic recognition of torque peak. 
The GUI for automatic torque peak recognition is shown with workflow marked above. 
The figure gives an example of manual removal of selected data point.  
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CHAPTER 3. NONCONTACT DIFFUSE CORRELATION SPECTROSCOPY/TOMOGRAPHY 
(NCDCS/NCDCT) FOR IMAGING OF MASTECTOMY SKIN FLAPS AND CHRONIC 
WOUNDS 
 
3.1 Introduction 
Skin flap necrosis is the most common complication after mastectomy and 
expander-implant based breast reconstruction, with an incident rate of up to 20% [6, 7, 
42]. Occurrence of flap necrosis is associated with insufficient blood supply in flap to 
meet the metabolic needs. Quantification of blood flow (BF) in mastectomy skin flaps is 
important for the prediction and early salvation of the flap necrosis. Fluorescence 
angiography has been used to measure tissue surface perfusion in the flap which may not 
reflect BF in deep tissue of the skin flap. Also, measurements with fluorescence 
angiography require invasive intravenous injection of dye. Furthermore, fluorescence 
signal is transient and thus not suitable for continuous monitoring [13-15]. Fluorescence 
imaging has been reported to over- or under-predict skin flap necrosis [15]. Therefore, a 
technique for noninvasive and continuous quantification of flap BF is desired.  
Chronic wounds affect more than 5 millions of Americans each year, among 
which the prevalence of limb chronic ulceration approaches 15 percent and this number 
keeps increasing [95]. The majority of chronic wounds can be classified into the 
following three categories accordingly: diabetic foot ulcer, pressure ulcer, and venous 
and arterial ulcers [3, 96]. Diabetic foot ulcers occur in 12 to 25 percent of patients with 
diabetes [97]. Shunts in the microcirculation, together with the presence of neuropathy, 
may lead to abnormal distribution of BF, which contributes to the wound development 
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and disturbs the healing of the wound site [98]. Pressure ulcer occurs after tissue is 
compressed over time. It originates from bone and develops upward to skin. Prolonged 
pressure applied to the wound site reduces blood perfusion, which is a key factor to 
prevent pressure ulcer from healing [4]. Peripheral arterial disease (PAD) is another 
major cause of chronic wounds because of ischemia due to micro circulation 
impairments. About 10 percent patients with PAD undergo vascular surgery to improve 
perfusion in their limbs [99]. Adequate perfusion and hemodynamic success are not only 
important judgment for revascularization surgery success, but also mandatory for healing 
of chronic wound [100]. Again, a noninvasive portable device for reliable measurements 
of BF distributions in wounds is needed for the diagnosis and treatment monitoring.   
For vulnerable tissues like skin flaps and wound tissues, contact measurements 
are not appropriate due to the risk of contact infections. On the basis of diffuse 
correlation spectroscopy (DCS) technique, we developed an innovative noncontact 
diffuse correlation spectroscopy and tomography (ncDCS/ncDCT) system for noncontact 
spectroscopic and tomographic measurements of blood flow distributions in relatively 
deep tissues [39, 41-43, 101]. The ncDCS/ncDCT system employs optical lens to project 
DCS sources and detectors on the tissue surface. A noncontact probe is mounted on a 
motorized-drive linear stage for mechanical scanning over a selected region of interest 
(ROI) for tomographic measurements. A finite element method (FEM) based diffuse 
correlation tomography (DCT) image reconstruction algorithm has been developed based 
on a modified open-source software package NIRFAST, which was originally designed 
for diffuse optical tomography (DOT) reconstruction [39, 41]. The ncDCS/ncDCT 
system has been validated in tissue-like phantoms and in in vivo tests. It has also been 
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applied for imaging of breast tumors and head/neck free tissue transfer flaps [39, 41, 82, 
101].  
In this project, I optimized and applied ncDCS for spectroscopic measurements of 
BF in mastectomy skin flaps intraoperatively with the hypothesis that ncDCS 
measurement could provide intraoperative BF data to enable the prediction of 
mastectomy skin flap necrosis [43].  I also applied ncDCT for tomographic imaging of 
BF distributions in chronic wounds to measure the BF contrast between wound tissue 
and normal tissue.  
 
3.2 Methods 
3.2.1 ncDCS/ncDCT instrumentation  
The ncDCS/ncDCT probe for noncontact blood flow measurement is shown in 
Figure 3.1. The noncontact probe has two identical laser source paths and one shared 
detector path in the center arranged in a linear array (Figure 3.1) [39, 41-43]. In each 
source path, laser light delivered through a multimode source fiber is projected onto the 
tissue surface through lens system (Figure 3.1). Fifteen single-mode detector fibers are 
evenly distributed in 7 mm to cover a 20 mm range on the focus plane (measurement 
surface) through the lens magnification (Figure 3.1). With this setup, the source-detector 
(S-D) separations range from 10 to 30 mm, which enables maximum penetration depth 
of ~15 mm (half of the S-D separation) [78, 81].  
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Figure 3.1 ncDCS/ncDCT probe and experimental setup for wound imaging. 
There are two separated source paths and one shared detector path integrated in the 
probe. Sources and detectors are projected/focused to tissue surface through lens 
apparatus. The noncontact probe is fixed to a motorized linear stage at ~10 cm above 
tissue surface. S-D: source-detector.  
 
This noncontact probe is connected to a DCS flowmetry device through optical 
fibers. Photons emitted from lasers are injected through the source path into the tissue 
sample. Photons travel through the tissue and reflect back to detectors (avalanche 
photodetector (APD)) through detection path. The correlator takes the APD outputs and 
44 
 
calculates the light intensity autocorrelation functions, which are used to extract tissue 
blood flow information. 
The noncontact optical probe is mounted on a linear motorized stage which is 
fixed to a multiple axis stand holder for flexible adjustment of probe position. The 
motorized stage can be fixed at one location for spectroscopic measurements or driven 
linearly using computer program for linear scanning over the ROI for tomographic 
measurements.  
 
3.2.2 DCT reconstruction  
Surface geometry acquisition and mesh generation. FEM-based DCT 
reconstruction requires incorporating a finite element mesh to represent the imaged tissue 
volume and to denote locations of the sources and detectors along the surface [39-41].  
For some simple cases, we may use a mesh with simple geometry, such as sphere or slab 
shape, to approximate the tissue geometry. While for many cases, the tissue surface 
geometry is complicated and requires more accurate geometry characterization for better 
reconstruction.  
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Figure 3.2 Mesh generation. 
The surface geometry (a) captured by the 3D camera is used to generate a surface shell 
(b). A solid body (c) representing the measured tissue volume is generated from the 
surface shell. Source and detector locations are calculated on the surface of the solid 
model based on the marks. Finally, the solid model is divided into a solid mesh (d).   
 
In this study, a commercial 3D scanner (NextEngine, CA) was used to scan target 
sample geometry. The working distance of the 3D scanner was about 17 inches from the 
sample surface. Prior to geometry acquisition, reference marks were made manually 
using marker pen on the measurement surface at the projected source locations of the 
beginning and ending step of the ncDCT scanning (Figure 3.2 (a)). These markers were 
used for assignment of sources and detectors on the mesh surface. During the 3D 
geometry scanning, a reference plane parallel to the focus plane of ncDCT was included 
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in the field of view (FOV) of 3D scanner for easy alignment of the geometric 
information and boundary ncDCT data. The output of the 3D scanner was the tissue 
surface geometry (Figure 3.2 (b)).  
A solid model was then created to extend the surface shell into a solid body 
(SolidWorks, Dassault Systemes, MA) (Figure 3.2 (c)). The projected sources and 
detectors were calculated based on this 3D model and the reference marks made on the 
tissue surface using a program implemented in SolidWorks interface (Figure 3.2 (c)) 
[40]. Finally, a 3D tetrahedron mesh was generated using ANSYS
® 
(ANSYS, PA) from 
the solid model created in SolidWorks with an appropriate node distance (typically 2 mm 
in this study) (Figure 3.2 (d)). 
Modified NIRFAST for DCT reconstruction. Many DOT methods have been 
developed for reconstructing 3D tissue heterogeneity from NIRS measurements at 
multiple S-D pairs [21-23]. For example, NIRFAST is a FEM-based open source 
software package for DOT image reconstruction [102]. Similar to DOT, DCT 
reconstructs blood flow image using DCS measurements from multiple S-D pairs. 
Because of mathematical similarity of the correlation diffusion equation (Equation 2.7) 
and the photon diffusion equation (Equation 2.2), the NIRFAST algorithm for DOT was 
modified and adapted by our group for DCT reconstruction [39, 102]: the term 
1
3
𝜇𝑠′ 𝑘0
2
 
𝛼〈∆𝑟 2 (𝜏)〉 in Equation 2.7 was written as 𝜇𝑎
𝑑(𝒓, 𝜏) = 2𝜇𝑠′ 𝑘0
2𝛼𝐷b(𝒓)𝜏, and defined as 
“dynamic absorption” at correlation delay time 𝜏.  DCT was conceptualized as a 
formulation of continuous-wave (CW) DOT (ω = 0) which computed 𝐺1 (𝒓, 𝜏) instead of 
photon fluence rate Φ(𝒓, ω), by updating “static absorption” 𝜇𝑎(𝒓) to 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏) = 𝜇𝑎(𝒓) 
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+ 𝜇𝑎
𝑑  (𝒓, 𝜏) at a selected 𝜏, and reconstructing 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓, 𝜏) instead of 𝜇𝑎(𝒓) only. The 
reconstructed 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 was used to extract 𝛼𝐷b (blood flow index (BFI)).  
Chart 3.1 shows the execution of DCT reconstruction using our modified 
NIRFAST. First, a mesh representing the imaged tissue volume is loaded. All the sources 
and detectors according to the actual ncDCT scanning are assigned onto the surface of 
the mesh. S-D pairs corresponding to the actual tissue boundary are linked to match with 
the boundary data. Initial guess of BFI and optical properties ((𝒓) and 𝜇𝑠′ (𝒓)) of each 
mesh voxel, along with the selected 𝜏 = 𝜏0 are assigned to the mesh. An initial guess of 
𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏0) is then calculated. Boundary BFI data from ncDCT scanning are converted 
to 𝑔1(𝒓, 𝜏0) using Equation 2.9 and further converted to 𝐺1(𝒓, 𝜏0) by multiplying with 
𝐺1(𝒓, 0) [39]. 
We then ran the inverse model with an iterative approach for the reconstruction of 
spatial distribution of 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏0) and BFI [39]. A forward model was first run to 
calculate the boundary 𝐺1(𝒓, 𝜏0) based on the initial guess of the mesh in the first 
iteration or based on the updated mesh in the following iterations. The discrepancy 
between the boundary 𝐺1(𝒓, 𝜏0) from our measurements and those from the 
initial/updated data was then calculated and minimized. If the reminding error was larger 
than the tolerance, an update for 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓, 𝜏0) is calculated accordingly.  These iterations 
ran continuously until the remaining error was under the tolerance. Finally, BFI 
distributions were extracted through the definition of 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏).  
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Chart 3.1 Flowchart of the modified NIRFSAT for DCT reconstruction.  
 
3.2.3 ncDCS for measurements of blood flow in mastectomy skin flaps 
Patient recruitment. The experimental protocol was approved by University of 
Kentucky (UK) Institutional Review Board (IRB) (#15-0511-F2L). Female patients over 
18 years old undergoing mastectomy and immediate breast reconstruction were recruited 
from the UK hospital with signed consent form.   
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Data collection & analysis. For each patient, blood flow was measured at three 
time points using ncDCS before and immediately after mastectomy, and immediately 
after breast reconstruction (Figure 3.3). For this study, one source path (laser at 785 nm) 
and 4 detector paths located at 10.0, 14.2, 18.6, and 22.8 mm distances from the source 
location were used to cover tissue flaps with penetration depths of 5 to 11.4 mm. At each 
time point, blood flow was measured from two to three equidistant locations along both 
sides of the edge of the mastectomy incision. Thirty frames of data were taken at each 
location. Total measurement time at each time point was less than 5 minutes.  
 
Figure 3.3 Mastectomy skin flap measurement setup. 
Measurement set up at before (a), immediately after mastectomy (b), and after breast 
reconstruction (c).   
 
BFIs were averaged over all locations and all S-D separations for each time point, 
and then normalized to the baseline level before mastectomy (assigning “1”) to get rBF. 
All subjects were followed for at least 5 months for the development of mastectomy skin 
flap necrosis defined as any area of skin necrosis on the skin flap. Statistical tests for 
averaged rBF differences at different time points were performed using Welch two 
sample t-test. The receiver operating characteristic (ROC) curve was constructed and the 
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area under the ROC curve (AUC) was calculated to evaluate the ability of rBF 
measurements to discriminate necrosis and non-necrosis groups. All analysis was 
performed using MATLAB.  
 
3.2.4 ncDCT for 3D imaging of chronic wounds 
Patient recruitment. The experimental protocol was approved by UK IRB (#14-
0571-F1V). We planned to recruit 20 patients with deep tissue wound (e.g., pressure 
ulcer, diabetic foot ulcer, arterial ulcer) in total from UK hospital Wound Care Clinic 
(WCC). Among the 20 subjects, we expected to recruit 10 PAD patients who will 
undergo revascularization and measure them twice at before and after the surgical 
intervention to evaluate hemodynamic improvements. The following populations were 
excluded during subject screening: 1) pregnant females; 2) patients under 18 years old; 
3) patients with very limited mobility. Because of the instrumentation limitation (i.e. 
limited coverage of the ncDCT probe), only patients with wound size under 100 × 20 
mm
2
 were considered for this study. Patients who passed our screening and agreed to 
participant in the study were measured at the UK Center for Clinical and Translational 
Science (CCTS).  
Data collection & analysis. For each measurement, tissue blood flow in the 
selected wound and the surrounding normal tissue (total coverage of ncDCT scanning on 
tissue surface: ~ 40 × 100 mm
2
, centered at the wound) were imaged using the ncDCT 
system (Figure 3.1). For this protocol, both source and detector paths on the ncDCT 
probe were used for noncontact scanning. Step separation (typically 6 mm) and total 
number of linear scan steps were determined based on the size of the wound (typically ~ 
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16 steps in total). Each scanning covered the wound and some surrounding normal tissue 
(total coverage: ~ 40 × 100 mm
2
, centered at the wound). At each step, 20 frames of data 
were obtained.  
During the measurement, the patient was asked to lie in the supine position (or 
bend over if the wound is on the back) to expose the wound site. Subsequently, ncDCT 
scanning was obtained using the noncontact probe. The scanning time ranged from 4 to 6 
minutes depending on the wound size and sampling density. A 3D photo was taken 
targeting the same location using the commercial 3D scanner to get tissue surface 
geometry. The actual source positions at the first and last steps were marked during the 
ncDCT scanning and included in the 3D photo for S-D coordinate. Each measurement 
took less than 30 minutes, including preparation, ncDCT scanning, 3D photo acquisition 
and wound bandaging after the optical measurements.  
For each measurement, 3D blood flow distribution in the wound and the 
surrounding normal tissue was reconstructed.  The scanning data was processed using 
Equation 2.5 and 2.9 to get a complete set of boundary 𝛼𝐷b. A mesh with real tissue 
geometry was generated using the method described in Chapter 3.2.2. The DCT 
reconstruction was done using our modified NIRFAST (Chapter 3.3.2). A single delay 
time 𝜏 = 3.2 × 10−6 𝑠, and optical properties of 𝜇𝑎 = 0.025 cm
-1
, 𝜇𝑠′ = 7.0 cm
-1
 were used 
in flow image reconstruction.  
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3.3 Results  
3.3.1 Prediction of mastectomy skin flap necrosis  
Nineteen patients were enrolled in the study. Four patients (21%) developed skin 
necrosis, one of which underwent additional surgery (patient #4). The rBF values 
immediately after mastectomy and after reconstruction of each patient are shown in 
Table 3.1. The difference in rBF immediately after mastectomy in patients with or 
without necrosis was statistically significant (Fig. 3.4 (a)), with values of 0.27 ± 0.11 and 
0.66 ± 0.22, respectively (p < 0.001). rBF values immediately after mastectomy showed 
a significant high accuracy in prediction of skin flap necrosis, with an AUC of 0.95 (95% 
confidence interval = 0.81, 1) (Fig. 3.4(b)).  
 
Table 3.1 rBF values in mastectomy skin flaps of 19 patients 
Patient Necrosis? 
Before 
mastectomy 
After 
mastectomy 
After 
reconstruction 
1 N 1 0.51 1.07 
2 N 1 0.51 1.39 
3 N 1 0.81 1.36 
4 Y 1 0.12 0.35 
5 N 1 0.8 0.45 
6 N 1 1.05 0.39 
7 Y 1 0.37 0.6 
8 N 1 0.81 0.58 
9 N 1 0.52 0.97 
10 N 1 0.24 0.5 
11 N 1 0.53 0.72 
12 Y 1 0.29 1.16 
13 N 1 1.07 0.91 
14 N 1 0.76 0.85 
15 N 1 0.72 1.04 
16 N 1 0.66 1.26 
17 N 1 0.52 0.52 
18 N 1 0.46 0.29 
19 Y 1 0.31 0.27 
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rBF after reconstruction showed the same trend with 0.58 ± 0.40 in patients who 
developed necrosis and 0.82 ± 0.36 in patients who did not develop necrosis ((Fig. 
3.4(c)(d)), while no statistical significance (p = 0.35) was observed. rBF values after 
reconstruction showed poor ability in prediction of skin flap necrosis, with an AUC of 
0.68 (95% confidence interval = 0.17, 1) (Fig. 3.4(d)).  
 
Figure 3.4 Prediction of mastectomy skin flap necrosis. 
(a) Relative blood flow changes (rBF) immediately after mastectomy from 19 patients 
including 4 with mastectomy skin flaps necrosis (patient 4, 7, 12, and 19, marked with 
black bars). Error bars represent rBF variations (standard deviations) at different depths 
of the mastectomy skin flap. (b) AUC data immediately after mastectomy for 
discriminating mastectomy skin flaps with necrosis (n = 4) and without necrosis (n = 15). 
(c) rBF after reconstruction from 19 patients. (d) AUC data after reconstruction for 
discriminating mastectomy skin flaps with necrosis (n = 4) and without necrosis (n = 15). 
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3.3.2 3D imaging of chronic wounds 
Five subjects with chronic wounds were recruited and measured. There was no 
PAD patient undergoing revascularization recruited in this study. Two of the five 
scanning were contaminated with significant motion artifacts since the patients moved 
significantly during noncontact scanning creating big difficulty for measurement 
alignment and were not processed for DCT reconstruction. The three successful cases 
included one with pressure ulcer, one with diabetic ulcer, and one with a non-healing 
traumatic injury.  
The pressure ulcer (Figure 3.5) and diabetic ulcer (Figure 3.6) had a circular 
wound with similar size (~1 cm in diameter). The non-healing traumatic injury case 
(Figure 3.7) had a long and narrow wound (~8 cm long and ~1 cm width). The 
reconstructed BF distributions showed similar pattern in the three cases: higher BF 
contrast (higher and lower rBF levels comparing to background) was found close to the 
wound. BF variations are seen both on the surface and in deep tissue while larger BF 
contrasts mainly appeared on the tissue surface close to the wound margin. In addition, 
blood flow variations were relatively smaller in the surrounding tissues away from the 
wound.  rBF contrasts (rBF relative to the normal surrounding tissues) over the 
reconstructed tissue volume were ranging from 0 to 4.0 in the pressure ulcer, from -0.2 to 
3.0 in the diabetic ulcer, and from 0.0 to 3.8 in the non-healing traumatic injury, 
respectively. 
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Figure 3.5 DCT results from the pressure ulcer case.  
(a) Surface color image overlays with the surface BF distributions. (b) Surface and cross 
section views of relative blood flow changes (rBF) distributions. 
 
 
Figure 3.6 DCT results from the diabetic ulcer case. 
(a) Surface color image overlays with the surface BF distributions. (b) Surface and cross 
section views of relative blood flow changes (rBF) distributions. 
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Figure 3.7 DCT measurement results from the non-healing traumatic injury case. 
(a) Surface color image overlays with the surface BF distributions. (b) Surface and cross 
section views of relative blood flow changes (rBF) distributions. 
 
3.4 Discussion and conclusions  
Prediction of mastectomy skin flap necrosis. We have demonstrated the 
feasibility of ncDCS for intraoperative measurements of tissue blood flow in the 
operating room without interfering with the sterility of surgical setup. The ncDCS has 
negligible risk comparing to other imaging modalities for intraoperative measurement 
because of the lack of dye injection or direct contact with patient.  
Patients who developed mastectomy skin flap necrosis had significantly lower 
rBF values at immediately after mastectomy (Figure 3.4(a)) comparing with patients 
who did not develop mastectomy skin flap necrosis, demonstrating the potential of 
ncDCS for the intraoperative prediction of necrosis risk [43]. Interestingly, the only 
patient (patient # 4) who required additional surgery had the lowest rBF immediately 
after mastectomy (Figure 3.4(a)), indicating a possible correlation between the 
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severity/extent of the mastectomy skin flap necrosis and the rBF value immediately after 
mastectomy. More subjects are needed to establish a model between risk level of 
necrosis and rBF values.  
rBF values after reconstruction showed the same trend that lower values were 
obtained from patients who developed mastectomy skin flap necrosis (Figure 3.4(c)) 
without reaching statistical significance. Furthermore, rBF after reconstruction 
demonstrated poor discriminating ability of mastectomy skin flap necrosis (Figure 
3.4(d)). rBF after reconstruction also showed larger variations comparing with those 
immediately after mastectomy (Figure 3.4), which may be partly attributed to the 
presence of the tissue expander or implant after reconstruction. 
3D imaging of BF distributions in skin flaps can significantly increase spatial 
resolution and enable precise prediction of necrosis volume and location for excision. 
However, limited by the long mechanical scanning time and poor spatial resolution, 
ncDCT imaging could affect surgical workflow in the operating room. 
Imaging of chronic wounds. We have successfully applied ncDCT technique for 
3D imaging of chronic wounds. Our preliminary results showed that tissue heterogeneity 
can be captured by the 3D imaging in relatively deep tissues. Given the burden of long-
term care for chronic wounds, this translational technology has the potential to facilitate 
better understanding of deep tissue wound development and healing process, and may 
lead to improvements in wound management and substantial cost savings in the future. 
For example, pressure ulcer originates from bone and develops upward to tissue surface. 
Hemodynamic changes in deep tissue occur before the ulcer is evident on tissue surface 
[4, 103]. Therefore, imaging of deep tissue hemodynamics in population with risk of 
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pressure ulcer may help on the prevention and early diagnosis of pressure ulcer. Previous 
study in PAD patients undergoing revascularization surgery showed that oxygenation 
level in the treated foot has significant increase after the surgery, indicating that 
hemodynamic measurement could be used to validate the success of the treatment [104]. 
Adequate perfusion and hemodynamic success are not only important judgment for the 
success of revascularization surgery, but are also mandatory for healing of chronic 
wound [100]. Thus, imaging of deep tissue hemodynamics should provide important 
information on the prediction of wound healing and on the validation of treatment 
outcome of various types of chronic wound.  
For the chronic wound study, we experienced difficulty in subject recruitment. In 
order to participant in this study, subjects were asked to travel from WCC after their 
clinic visit to CCTS. Although free public transportation and free parking were available, 
it was still hard and inconvenient for the potential subjects since most of them had other 
chronic diseases or health issues besides the wound, which all together limited their 
mobility significantly. In addition, because of the limited coverage of the ncDCT system, 
only small wounds were imaged.  
Limitations of ncDCS/ncDCT system. The ncDCS/ncDCT system has some 
limitations when applying in clinical settings. The motorized linear stage enables lateral 
scanning along the surface of ROI and allows relatively dense sampling by assigning 
relative short step separation. However, the fixed linear S-D array limits longitudinal 
coverage of scanning and leads to poor spatial resolution. Motion artifacts may 
contaminate boundary data and result in difficulty for S-D alignment. The step-by-step 
scanning in relatively low speed also makes ncDCT system impractical for catching fast 
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transient changes in tissue hemodynamics. Since ncDCS/ncDCT system uses optical 
fibers and expensive APDs, it is difficult to improve temporal and spatial resolution. 
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CHAPTER 4. SPECKLE CONTRAST DCT (SCDCT) FOR IMAGING OF WOUNDS 
 
4.1 Introduction 
Imaging of blood flow (BF) distributions in burn wounds can provide essential 
information for determining the ischemic area that requires wound excision or skin 
grafting to ensure successful surgical outcomes [1]. As reviewed early in Chapter 3, 
although noncontact diffuse correlation spectroscopy and tomography (ncDCS/ncDCT) 
can measure BF distributions in vulnerable tissues including wounds, they have limited 
temporal and spatial resolution and limited size of region of interests (ROI) for BF 
imaging because of limited sources/detectors and long mechanical scanning. Very 
recently, our lab proceeded from avalanche photodetector (APD) to camera detection for 
blood flow imaging, which significantly increases temporal/spatial resolution and 
eliminates the needs of mechanical scanning. This novel optical imaging technique is 
termed speckle contrast DCT (scDCT) [44-46]. The scDCT employs a focused point 
source and a galvo mirror to remotely project point light onto source locations over a 
selected ROI. The optical zoom lens in front of the camera enables fully noncontact 
detection of BF and flexible adjustment of ROI. As mechanical scanning is no longer 
needed, scDCT enables fast data acquisition, which is desirable for use in the operating 
room. Thousands of pixels provided by the camera significantly improve spatial 
resolution of imaging. The scDCT system has been tested for BF imaging using tissue-
simulating phantoms and in vivo tissues.  
61 
 
The scDCT technique extracts boundary BF information from the spatial 
distribution of diffuse laser speckles detected by the camera. Boundary BF data is input 
to the modified NIRFAST program (see Chapter 3.2.2) for three dimensional (3D) 
tomographic reconstruction of BF distributions. In addition, we have developed two 
dimensional (2D) mapping method, which requires less computation time (several 
minutes) compared to 3D reconstruction (several hours) [105], although it sacrifices the 
depth information. 
One limitation with the current scDCT technique is the potential influence of 
unknown tissue optical properties such as µa on BF measurements [25, 47, 106]. For the 
current approach of blood flow index (BFI, i.e. αDB) quantification from diffuse speckle 
contrasts, we assume constant optical properties (absorption coefficient:𝜇𝑎 , reduced 
scattering coefficient: 𝜇𝑠
′ ) for the entire tissue volume. However, it has been reported that 
different types of tissues or tissues with different diseases have varied optical properties 
[85, 107]. Assuming inaccurate optical properties may lead to error in αDB calculations 
[108-110]. Therefore, new algorithms to overcome this limitation are desired [106, 109, 
111].  
In this study, I optimized and tested the scDCT system using tissue-simulating 
phantoms and in human forearms with arterial occlusions to validate the capability of the 
scDCT system on imaging spatial and temporal flow changes. I applied the scDCT 
system for the first time to image burned wounds [47]. Lower BF was expected in burnt 
tissue comparing with surrounding normal tissue. I also developed and validated a new 
algorithm for extracting both αDB and 𝜇𝑎 from the measured light intensities and speckle 
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contrasts at multiple S-D distances collected by scDCT system in order to get rid of the 
influence of  𝜇𝑎 on αDB calculation. 
 
4.2 Methods 
4.2.1 scDCT instrumentation 
Figure 4.1 shows the scDCT system configuration [45]. Two cameras were tested 
including an electron-multiplying charge coupled device (EMCCD; Cascade 1K, 
Photometrics, AZ) and scientific complementary metal–oxide–semiconductor (sCMOS; 
Hamamatsu Orca Flash 4.0LT) in the scDCT system. Camera specifications are listed in 
Table 4.1. The sCMOS camera has higher frame rate (30 frame per second (fps)) 
comparing with the EMCCD (~10 fps), which benefits a faster sampling.  
 
Table 4.1 Specifications of Cascade 1K and Orca Flash 4.0LT 
 Cascade 1K Orca Flash 4.0LT 
Sensor type EMCCD sCMOS 
Pixel number 1004 × 1002 2048 × 2048 
Pixel size 8 µm × 8 µm 6.5 µm × 6.5 µm 
Sensor size 8.032 mm × 8.016 mm 13.312 mm × 13.312 mm 
Well capacity 30,000 30,000 
Frame rate 10Hz 30Hz 
AD conversion 16 bits 16 bits 
 
The camera with a large number of pixels increases significantly sampling density 
and spatial resolution. It also eliminates the need of mechanical scanning in ncDCT, and 
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thus shortens the measurement time and avoids motion artifacts. NIR point-source light 
at 830 nm from a long-coherence laser (Crystalaser) is delivered through a multimode 
fiber (core size: 200 microns) to an achromatic lens (AC127-019-B, Thorlabs), and then 
to a galvo mirror (GVS002, Thorlabs). The galvo mirror projects NIR light to different 
source positions in ROI. Very recently, a pinhole was added into the source light path 
between the achromatic lens and the galvo mirror to sharpen the projected laser spot on 
the measured tissue/phantom. 
 
 
Figure 4.1 scDCT system configuration.  
The EMCCD/sCOMS camera is focused by a zoom lens onto the tissue surface. A long 
coherence laser is connected through an optical fiber to lens and polarizer. The focused 
source light spot is projected by the galvo mirror onto the measured tissue surface. S1: 
source 1, D1/D2: detector 1/2. 
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A zoom lens (Zoom 7000, Navitar) is mounted to the camera enabling easy 
adjustment of ROI. The camera detects diffuse light from tissue surface in a reflectance 
mode, which is more practical and flexible for applications in large volume tissues, 
where transmission mode is impractical due to limited penetration depths of light. In 
order to reduce the direct reflection of the source light from the tissue surface, a pair of 
polarizers (LPNIRE050-B and LPNIRE200-B, Thorlabs) is added in source light path 
and in camera detection path. A long-pass filter (84-762, Edmund Optics, NJ) is added in 
front of the zoom lens to minimize the influence of room light. The noncontact scDCT 
probe is fixed on an articulated arm for flexible positioning and accurate focusing on the 
ROI. The scDCT system is controlled by a LabView program for accurate projection of 
source light to desired locations and the sequential collection of images.  
 
4.2.2 3D reconstruction of blood flow distributions 
The concept of speckle contrast comes from laser speckle contrast imaging, where 
typically a wide-field illumination is applied over a ROI and a camera is used for 
detecting laser speckle fluctuation on superficial tissue surface [112, 113]. By contrast in 
scDCT technique, a focused point laser source is used to deliver NIR light into the deep 
tissue. An EMCCD/sCOMS camera is used to detect diffused laser speckle fluctuation, 
resulting from motion of red blood cells. The diffuse speckle contrast is defined as:  
Ks(r) = 
σ𝑠
〈I〉
 ,      (4.1) 
Here, σs is the spatial or temporal standard deviation of light intensity and 〈I〉 is 
the mean intensity of a set of pixels, r is the distance of the pixels from the source 
location.  
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From the Siegert relationship (Equation 2.5), the speckle contrast Ks(r) can be 
related to the temporal correlation function g1 as the following [44]: 
Ks(r)
2
 = 
2β
𝑇
 ∫  
𝑇
0
(1− 
𝜏
𝑇
) [g1(r, τ)]
2
 dτ;      (4.2)  
Where T is the exposure time.  
By substituting g1 with its analytical solution (Equation 2.9) to Equation 2.7 in 
semi-infinite geometry, a nonlinear relationship between Ks(r) and αDB can be 
established, where Ks(r) can be written as a function of αDB, together with other 
parameters [44]:  
Ks(r)
2
 = 𝑓(αDB, 𝑇, 𝜇𝑎, 𝜇𝑠′, 𝜆, 𝛽, 𝑘0, 𝒓)     (4.3) 
Where 𝜆 is the wavelength of the source light and 𝑘0 is the wavenumber. For each 
fixed set of αDB, 𝜇𝑎, 𝜇𝑠′, 𝜆, 𝛽 and 𝑘0, the nonlinear relationship between the diffuse 
speckle contrast (K), S-D separation (𝒓) and exposure times (T) is shown in Figure 4.2.  
 
Figure 4.2 Variations in speckle contrasts over a range of S-D separations and 
exposure times. 
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We extract αDB from the speckle contrast at a single S-D separation and a single 
exposure time (i.e., a single data point on the surface shown in Figure 4.2) [44, 45]. The 
speckle contrast can be experimentally measured and calculated (Equation 4.1) from 
images taken by the camera. In the right-hand side of Equation 4.3, 𝑇, 𝜆, 𝑘0 and 𝒓 are 
known or measurable, 𝜇𝑎, 𝜇𝑠′ and 𝛽 can be estimated from literatures. Therefore, αDB is 
the only unknown variable. By assigning a value for αDB, a theoretical diffuse speckle 
contrast can be calculated using Equation 4.3. Finally, αDB is determined by searching 
for the value of αDB that minimizes the square difference between the measured speckle 
contrast and the theoretical speckle contrast.  
The αDB extracted from scDCT is equivalent to that obtained from APDs 
measurement in ncDCT as introduced in Chapter 3. Therefore, scDCT reconstruction of 
3D blood flow distributions can be performed in the same manner as ncDCT [44, 45].  
 
4.2.3 2D mapping of blood flow distributions 
2D mapping of BF distributions projects boundary BF measurements onto a 2D 
mesh of FOV, which saves computation time comparing with DCT reconstruction. The 
procedures of 2D mapping are introduced below [105]. For each linked S-D pair, BFI is 
first calculated using the method introduced in Chapter 4.2.2. The midpoint was then 
calculated for the S-D pair as the center location between the source and the detector 
(Figure 4.3). The boundary BFI is then projected to the midpoint location to represent 
the S-D pair. This is because the midpoint matches better to the realistic sensitive region 
of the diffuse light with a banana photon pathway for the manipulated S-D pair.  
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Figure 4.3 Flowchart of 2D mapping algorithm.  
S-D: source-detector. 
 
 
After BFI and midpoints over all linked S-D pairs are calculated, spatial merging 
and smoothing are done. For each midpoint, a subset of S-D pairs within a neighborhood 
radius based on midpoint location is identified. The average or weighted average of the 
BF measurements corresponding to this subset are calculated and projected to the 
manipulated midpoint location as the final BF value for this location.  
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4.2.4 Phantom tests 
Tissue-like phantoms with known optical properties are commonly used in optical 
instrument calibration and validation. The liquid phantom consists of distilled water, 
India ink (Black India, MA) and intralipid (Fresenius Kabi, Sweden). The intralipid 
particles in the liquid phantom provide control of μ𝑠
′  and Brownian motion (particle 
flow) while India ink provides control of µa.  
In this study, the optical properties of the homogeneous phantom were set as µa = 
0.05 cm
−1
 and μ𝑠
′  = 8 cm
−1
 to match the realistic biological tissues. The homogeneous 
liquid phantom was filled into a water tank as the background. Two heterogeneous 
phantoms were created to validate the scDCT system by embedding two different 
anomalies with increased or decreased flow contrast respectively into the homogeneous 
phantom.  
In the first heterogeneous phantom, a transparent plastic cylindrical tube 
(diameter = 6 mm, length = 80 mm) connected with a peristaltic pump (HV-77201-60, 
Cole Parmer, IL) through soft rubber tube was placed 5 mm (tube center to liquid 
phantom surface) beneath the surface of the background liquid phantom to create high 
flow contrasts at different levels against the background liquid phantom. The tube lay 
across the center of ROI along x direction (Figure 4.4 (a)). The tube was mostly stuffed 
with small pieces of solid phantom (composition: titanium dioxide, silicon and carbon 
black) with the same optical properties as the background liquid phantom to randomize 
the particle motion as random flow inside the tube. The tube was then filled with the 
same liquid phantom and the liquid was pumped by the pump to create step increases in 
steady flow from 0 to 20 ml/min at 5 ml/min increment in the tube.  
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In the second heterogeneous phantom, two sphere shape solid phantoms (μa = 
0.05 cm
−1
, μ𝑠
′  = 8 cm
−1
, flow = 0) at diameter of ∼7 mm were placed at 5 mm (sphere 
center to background phantom surface) beneath the surface of background liquid 
phantom at the locations of X-Y planes (15, 15 mm) and (−15, −15 mm) respectively to 
create low flow contrasts against the background liquid phantom (Figure 4.4 (a)). A thin 
iron wire penetrating through the centers of the two sphere solid phantoms was used to 
hold the two anomalies in place.  
 
Figure 4.4 Phantom tests with scDCT.  
(a) Source-detector (S-D) configuration for phantom tests: region of interests (ROI) = 80 
× 80 mm
2
; dimension and locations of anomalies. (b) S-D configuration for forearm 
occlusion test: ROI = 40 × 40 mm
2
 
 
For scDCT data collection, the EMCCD (i.e., Cascade 1K in Table 4.1) was used. 
An ROI of size 80 × 80 mm
2
 was selected to cover the anomalies region (Figure 4.4 (a)). 
The galvo mirror projected 830 nm source light to 9 × 9 source locations (1 cm 
separation from each) in the ROI. For each scanning, 4 frames of EMCCD images were 
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taken at each source location. 41 × 41 detectors (2 mm separation from each) were 
evenly defined in the ROI for image reconstruction. Sources and detectors within S-D 
separation range of 7 to 19 mm werelinked for boundary data calculation and DCT 
reconstruction. Image reconstructions were processed using a 100 × 100 × 30 mm
3
 slab 
mesh centered at (0, 0, 15 mm) with 4 mm distance nodes and refined 1.3 mm distance 
nodes in the center (∼60K nodes in total) to improve the reconstruction resolution in the 
targeted area. 
 
4.2.5 Imaging of forearm blood flow 
The scDCT is tested for continuous imaging of BF changes in a healthy human 
forearm. The BF change in forearm was induced by a 4-minute arterial occlusion at a 
pressure of 230 mmHg applied on the upper arm. The EMCCD (i.e., Cascade 1K in 
Table 4.1) was used in this test. An ROI of 40 × 40 mm
2
 was selected on the subject’s 
forearm (Figure 4.4 (b)). 5 × 5 sources separated by 1cm of each were used for the data 
collection. 21 × 21 detectors were evenly defined for boundary BF calculation. Image 
reconstruction was processed on a 60 × 60 × 30 mm
3
 slab mesh centered at (0, 0, 15 mm) 
with 2 mm distance nodes (∼20K nodes in total). 
 
4.2.6 Imaging of wounds  
The experimental protocol has been approved by University of Kentucky (UK) 
Institutional Review Board (IRB) (#14-0571-F1V) [47]. Patients with burn wound were 
recruited from UK hospital. scDCT imaging was done in the operating room prior to 
wound excision and grafting (Figure 4.5 (a)). The EMCCD (i.e., Cascade 1K in Table 
71 
 
4.1) was used in this study. A ROI of 80 × 80 mm
2
 was selected to cover an area with 
burned tissue and adjacent unburnt tissues. 9 × 9 sources were evenly distributed over the 
ROI with 1 cm separation between each for data acquisition (Figure 4.5 (b)). The 
exposure time used in this study was 5 ms. Two frames of raw images were acquired and 
averaged at each source location.  
 
 
Figure 4.5 Imaging of BF distributions in burn wounds with scDCT system.  
(a) Experimental set up in the operating room. scDCT imaging is focused onto the 
selected area across the burned wound and surrounding normal tissue. (b) The source-
detector arrangement over the region of interests. 
 
41 × 41 detectors with 2 mm separation between each were evenly defined over 
the ROI (Figure 4.5 (b)). Each detector region was defined as binding 3 × 3 adjacent 
pixel windows while each pixel window consisted of 7 × 7 pixels. Spatial speckle 
contrast was first calculated for each of the 9 pixel windows. Speckle contrast of the 
detector was then calculated by averaging the speckle contrasts over the 9 pixel windows 
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and over the two frames to enhance signal-to-noise ratio [44, 45]. S-D separation was 
calculated as the distance from the center of the source light spot to the center of each 
detector region. Pre-processing of raw data including shot noise removal, dark noise 
removal and smear correction were performed prior to speckle contrast calculations. 
Speckle contrasts at the S-D separations of 7 to 19 mm were then calculated as boundary 
data [44, 45]. 
Boundary BFI data were normalized to their mean value (assigning “1”) to 
calculate relative change of BF (rBF). The normalized boundary rBF were then used as 
input for 3D tomographic reconstructions of BF distributions in the targeted tissue 
volume using the modified NIRFAST and for 2D mapping of BF distributions. For the 
3D reconstruction, a slab shape tetrahedral mesh with a volume of 100 × 100 × 30 mm
3
 
and node distance of 2 mm was used for 3D image reconstruction. In this study, we only 
recruited patients with burn on body part(s) with relatively flat surface. Thus, a slab 
mesh was used to approximate tissue geometry without introducing much errors related 
to irregular geometry. A neighborhood radius of 6 mm was used for 2D mapping. 
Results from 3D reconstruction and 2D mapping were compared.  
 
4.2.7 Simultaneous extraction of absorption coefficient (µa) and blood flow index 
(αDB)  
Recalling Equation 4.3, speckle contrast is a function of multiple parameters 
including αDB and optical properties (µa and µs
’
). The assumption of optical properties 
may lead to errors in αDB calculations. Therefore, developed a new algorithm that 
enables extraction of both µa and αDB from the measured light intensities and speckle 
73 
 
contrasts at multiple S-D distances. This algorithm employs a two-step approach: first, µa 
is calculated from the measured light intensities at multiple S-D distances; second, αDB 
is calculated from the speckle contrast at multiple S-D distances with the input of µa 
obtained in the first step. Details of these steps are described below.   
The simplified solution of photon diffusion equation is given as [23, 105, 111]:  
ln[I(r) r
2
] = k – r 𝜇𝑒𝑓𝑓       (4.4) 
Here I(r) is the light intensity I at S-D separation r, k is a constant, μ𝑒𝑓𝑓 is the 
effective attenuation coefficient defined as: 
𝜇𝑒𝑓𝑓 (λ) = √3 𝜇𝑎(𝜆) ∙  𝜇𝑠′ (𝜆)       (4.5) 
Note that the premise of Equation 4.4 is r ≥ 1cm [23, 105]. ln[I(r) r
2
] 
approximately has a linear relationship with r when this condition is met. μ𝑒𝑓𝑓 can be 
fitted from light intensities at multiple S-D distances since μ𝑒𝑓𝑓  is the slope in this linear 
model. By assuming 𝜇𝑠
′ , 𝜇𝑎 can be calculated by fitting μ𝑒𝑓𝑓 (Figure 4.6 (a)).  
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Figure 4.6 Two-step approach for extraction of µa and µs’.  
(a) Fitting effective attenuation coefficient (µeff) from light intensities measured at 
multiple source-detector (S-D) separations. (b) Fitting blood flow index (αDB) from 
speckle contrasts measured at multiple S-D separations.  
 
 
The second step of the algorithm is to fit αDB from the measured speckle contrasts 
at multiple S-D distances by minimizing the penalty term defined as [106, 109, 110, 
114]: 
 χ
2
 = ∑  
𝑁𝑟
𝑖=1 [ 𝐾𝑚
2 (𝑟𝑖, αDB) - 𝐾𝑡
2(𝑟𝑖, αDB) ]
2
    (4.6) 
Here, 𝐾𝑚
2  is the experimentally measured speckle contrast and 𝐾𝑡
2 is the 
theoretical speckle contrast with assigned αDB calculated using Equation 4.3. In order to 
eliminate the influence of the linear scaling factor 𝛽 in Equation 4.3, we normalize both 
𝐾𝑚
2  and 𝐾𝑡
2  to their mean over all the selected r respectively to cancel 𝛽 from the 
calculation (Figure 4.6 (b)) [110]. 
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In addition to the improvement on quantification of αDB, assessment of 𝜇𝑎  at 
multiple wavelengths (λ) would enable the quantification of [Hb] and [HbO2] (see 
Chapter 2.2.1).  
 
4.2.8 Phantom tests for simultaneous extraction of µa and αDB 
The high sensitivity sCMOS camera (i.e., Orca Flash4.0LT in Table 4.1), which 
has better sensitivity in photon sensing, was used in this test.  
The pinhole added in the source light path was further optimized for this test to 
minimize the influence of the projected laser spot to the diffuse speckle at relatively short 
S-D separations, which is critical for the tested algorithm since speckle contrast at short 
S-D separations are more sensitive to the change of αDB. There is a trade-off for the 
opening of pinhole: the smaller the laser spot is the better signal at short S-D separations; 
however, more light is blocked by the pinhole so the signal to noise ratio (SNR) 
decreases especially at larger S-D separations. In this study, we optimized the pinhole 
opening to get valid data at S-D separations around 3 mm up to around 20 mm. Figure 
4.7 shows a comparison of normalized speckle contrast at multiple S-D separations 
without (Figure 4.7 (a)) and with (Figure 4.7 (b)) the optimized pinhole in the source 
path.  
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Figure 4.7 Effect of pinhole optimization. 
(a) Before pinhole optimization: the shortest valid source-detector (S-D) separation was 
around 10mm. (b) After pinhole optimization: the shortest valid S-D separation was 
shorten to around 3mm. 
 
The new algorithm requires input of measured light intensities and speckle 
contrasts at multiple S-D separations. At this preliminary stage, our tests were done with 
one source located at the center of the FOV (Figure 4.8 (a)). We then optimized the 
parameters of the camera and the lens system based on this configuration.  
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Figure 4.8 Definition of pixel windows.  
(a) Experimental set up for phantom test of the new algorithm. The source location is 
fixed at the center of field of view. (b) Pixel window definition in the blue box region 
marked in (a): each cluster of pixels with same color is assigned as one pixel window.  
 
A field of view (FOV) of 90 × 90 mm
2
 was selected to ensure up to 30 mm S-D 
separations in all directions. To fulfill the Nyquist sampling criteria that the minimum 
speckle size (ρspeckle) must be two times larger than the camera pixel size (ρpixel), the 
following equation gives the lower limit of F# [115]: 
ρspeckle = 2.44λ (1+M) F# ≥ 2ρpixel    (4.8) 
Here, M is the magnification of the imaging system, which is camera sensor size 
(i.e., 13.312×13.312 mm
2
) divided by the size of FOV (90×90mm
2
). The calculation 
results suggest that the minimum F# for the current setting is 6.4.  
Several combinations of exposure time (T = 1, 2, 3, 5ms) and F# (6.4, 8, 11) were 
tested on tissue like phantoms with varied μ𝑎  levels (0.04 cm
-1
 to 0.16 cm
-1
). The 
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combination of T = 2ms and F# = 8 gives the best data quality and this is used in the 
following tests.   
Experimental design for phantom tests. To examine the performance of the 
new algorithm, we performed tissue-like liquid phantom tests using the above-mentioned 
configuration and parameters (FOV = 90 × 90 mm, T = 2 ms, F# = 8). A glass tank was 
filled with the liquid phantom that consisted of distilled water, India ink (Black India, 
MA) and Intralipid (Fresenius Kabi, Sweden). 
As the new algorithm aimed to extract μ𝑎 and αDB from scDCT data, we varied 
μ𝑎 and αDB of the phantom respectively, while μ𝑠
′  was set at 10 cm
-1
 throughout the test. 
At each step, 50 frames of images were taken using the scDCT system. For validation, 
near infrared spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS) 
measurements were also conducted on the tissue phantoms using a hybrid contact probe.  
Indian ink titration was done to create gradient in μ𝑎 from 0.04 cm
-1
 to 0.16 cm
-1
 
with 0.03 cm
-1
 increment per step, while concentration of intralipid was kept constant 
with μ𝑠
′  = 10 cm
-1
 and αDB = ~1 × 10
-8
 cm
2
/s. For each titration step, the phantom was 
stirred thoroughly and then rested for 2 minutes to allow it to come back to static before 
data collection by scDCT and NIRS/DCS.  
Changes in Brownian motion (αDB) were created by changing the temperature of 
the phantom from 5°C to 25°C (fridge to room temperature). The μ𝑎  and μ𝑠
′  were 
controlled at 0.1 cm
-1
 and 10 cm
-1
 respectively during the flow titration. Data was 
collected at each increment of 5°C using scDCT and NIRS/DCS devices. The 
temperature was monitored by a thermometer throughout the test and recorded when 
optical data were collected.  
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For each raw image, dark noise and shot noise were removed before speckle 
contrast calculation. Note that, sCMOS camera (i.e., Orca Flash 4.0LT in Table 4.1) 
used in this study does not have smear effect as the EMCCD (i.e., Cascade 1K in Table 
4.1) had. Spatial speckle contrasts and light intensities in all directions around the source 
were calculated in S-D separations ranged from 0.25 to 35 mm, with increment of 0.5 
mm. For each S-D separation r0, all pixels within (r0 – 0.2) mm ≤ r ≤ (r0 +0.2) mm were 
selected and segmented into pixels windows of 50 adjacent pixels (Figure 4.8 (b)). 
Speckle contrasts of each pixel window were calculated using Equation 4.1 and then 
averaged over all the pixel windows to get the speckle contrast at r0. Similarly, light 
intensities at each S-D separation were calculated and averaged using the same pixel 
window assignment for each image. Finally, speckle contrasts and light intensities at 
multiple S-D separations were averaged over 50 frames of images for each S-D 
separation.    
Light intensities at S-D separations of 10 to 20 mm were used to fit μ𝑎. Speckle 
contrasts at S-D separations of 3 to 15 mm were used to fit αDB. For the validating 
measurements using NIRS/DCS, μ𝑎 and μ𝑠
′  were first calculated from NIRS data at each 
step. αDB was then calculated from DCS data with μ𝑎  and μ𝑠
′  measured by NIRS as 
inputs.  
The μ𝑎 and αDB fitted from the new algorithm were compared with NIRS/DCS 
measurement results. Percent error in the fitted data with the new algorithm was 
calculated by taking NIRS/DCS data as gold standard (i.e., error = 100% × │fitted - 
standard│/standard). Linear regression of μ𝑎in ink titration was conducted between the 
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NIRS data and scDCT data with the new algorithm. Linear regression of αDB was also 
conducted between DCS and scDCT measurements.  
 
4.3 Results 
4.3.1 Phantom test results 
Figure 4.9 (a) shows the cross-section view of the reconstructed flow distribution 
at pump speed of 20 ml/min cross the tube anomaly center. The tube shape was clearly 
reconstructed. Reconstructed anomaly was determined by a half-maximum threshold and 
the reconstructed anomaly flow at each pump speed was calculated as the mean αDB in 
the reconstructed anomaly region.  
 
 
Figure 4.9 The reconstructed 3D images of tube flow contrasts.  
(a) Cross section views of x direction at pump speed of 20 ml/min. (b) Linear regression 
between the reconstructed percentage flow changes and relative flow changes by the 
pump. 
 
For comparison, the reconstructed anomaly flow contrasts were normalized to the 
averaged step difference of αDB. The pump speeds were normalized to the step 
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difference (i.e., 5 ml/min). Figure 4.9 (b) shows the linear regression between the 
reconstructed percentage flow changes and the relative flow changes pumped in the tube.  
Perfect linear relationship was observed (y = 0.94x + 8.47, R
2
 = 0.99, and p < 10
−5
).  
Figure 4.10 (a) illustrates the cross-section views of the reconstructed flow 
contrast of the two anomalies in the liquid phantom. Figure 4.10 (b) shows the cross-
section views of X-Y plane at different depths (0, 3, 6 and 9 mm) below the phantom 
surface. Similarly, the reconstructed anomalies were determined by a half-maximum 
threshold. The averaged flow contrasts in the two reconstructed anomalies are 0.32 and 
0.25 (relative to a background flow assigning 1). The reconstructed center locations of 
the two anomalies are (14.2, 15.4, 24.5 mm) and (-14.4, -15.3, 25.8 mm), which are close 
to the designed locations (15.0, 15.0, 25.0 mm) and (-15.0, -15.0, 25.0 mm), respectively. 
The reconstructed anomaly diameters are 8.6 and 7.1 mm, which are close to the 
diameter of the solid sphere phantoms (∼7 mm).  
 
Figure 4.10 Reconstructed images of spherical phantoms flow contrasts.  
(a) Cross section views cross the center of the two spherical anomalies. (b) Cross section 
views of X-Y plane at the depths of 0, 3, 6 and 9 mm below the phantom surface. 
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4.3.2 Human forearm test results 
Figure 4.11 shows the reconstructed 3D forearm BF images during baseline (T1) 
(Figure 4.11 (a)), cuff occlusion (T2) (Figure 4.11 (b)), reactive hyperemic peak flow 
(T3) (Figure 4.11 (c)), and recovery (T4) (Figure 4.11 (d)). Figure 4.11 (e) shows time 
sequence of BF changes relative to resting baseline in the selected two tissue volumes 
(marked on Figure 4.11 (a)) of ∼5 mm3 centered at (0, 0, 25 mm) and (16, 16, 25 mm), 
respectively. The spatial averaged rBF values inside the two tissue volumes at the four 
measurement time points (T1 to T4) shown in Figure 4.11 (e). The rBF trends 
throughout the occlusion protocol are consistent in the two selected tissue volumes with 
some spatial heterogeneity. The rBF trends and variation level agreed well with previous 
results. These results demonstrate the feasibility of scDCT for 3D in vivo imaging of BF 
distributions in deep tissue. 
 
Figure 4.11 Reconstructed 3D images of forearm blood flow during cuff occlusion.  
Forearm flow images at the periods of baseline (a), cuff occlusion (b), reactive hyperemic 
peak flow (c), and recovery (d). (e) Time sequence of flow changes in the selected two 
tissue volumes marked in (a).  
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4.3.3 3D and 2D imaging of wounds 
Two patients with full thickness burn wounds were enrolled in this study [47]. 
Figure 4.12 shows imaging results from Patient #1. Figure 4.12 (a) shows the surface 
color photo of the selected ROI that covers the areas of full thickness burn, partial 
thickness burn, and surrounding unburnt tissue. The boundaries across the burn and 
unburnt tissues are marked with blue lines. Figure 4.12(b) shows the reconstructed 2D 
cross-section views of rBF distributions in the targeted tissue at different depths of 0, 3, 
6, and 9 mm below the tissue surface. Each cross-section was averaged from mesh nodes 
located within ± 0.2mm range from the center depth. The average rBF values in the full 
thickness burn volume, the partial thickness burn volume, and the normal tissue volume 
were 0.97 ± 0.054, 1.01 ± 0.053, and 1.04 ± 0.062 (mean ± standard deviation), 
respectively (Figure 4.12). One-way ANOVA test revealed significant differences in 
rBF among different tissue volumes (p < 0.001). Post-hoc tests in ANOVA suggested 
significant differences in rBF for each of pair-wise comparison across different tissue 
volumes (p < 0.001). In addition, spatial variations in rBF existed across the ROI and 
over different depths. Figure 4.12 (c) shows the 2D mapping of BF distributions which 
agreed with the DCT reconstruction results.  
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Figure 4.12 BF Distribution in Patient #1.  
(a) A photo of the imaged region. (b) 2D cross-section views of relative blood flow (rBF) 
distributions at the depths of 0, 3, 6, and 9 mm. (c) 2D mapping of rBF. 
 
Figure 4.13 shows the imaging results from Patient #2. Similarly, significant 
lower rBF values (0.92 ± 0.078) were observed in the eschar volume (Figure 4.13), 
compared to the surrounding tissue volume (1.06 ± 0.079, p < 0.001, two sample t-test). 
Spatial variations in rBF existed across the ROI and over different depths. Note that the 
wound in Patient #2 was a burn combined with pressure ulcer, diagnosed during wound 
excision. In addition, the range of rBF variation in Patient #2 (0.8 to 1.4) was larger than 
that in Patient #1 (0.9 to 1.2). Figure 4.13 (c) shows the 2D mapping of BF distribution; 
similar flow pattern was seen as observed in 3D image.  
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Figure 4.13 BF Distribution in Patient #2.  
(a) A photo of burn/wound region. (b) 2D cross-section views of relative blood flow 
(rBF)  distributions at the depths of 0, 3, 6, and 9 mm. (c) 2D mapping of rBF.  
 
4.3.4 Phantom test results for simultaneous extraction of µa and αDB 
Results of ink titration and temperature variation are shown in Figure 4.14 and 
Figure 4.15. Comparison of μ𝑎 and αDB values obtained from the scDCT with the new 
algorithm and from NIRS/DCS are reported in Table 4.2. Linear regressions between 
these measurements are shown in Figure 4.16.  
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Table 4.2 Summary of phantom test results 
 
𝛍𝐚 (cm
-1
)  𝛂𝐃𝐛 (*10
-8 
 cm
2
/s)  
reference fitted Error (%) reference fitted Error (%) 
Ink titration 
test 
0.040 0.033 15.97 1.08 1.02 5.31 
0.073 0.068 6.21 1.22 1.19 3.05 
0.100 0.097 3.30 1.28 1.35 5.80 
0.127 0.130 2.29 1.10 1.24 13.23 
0.155 0.157 1.13 1.11 1.62 45.42 
Temperature 
varying test 
0.099 0.099 0.49 0.77 0.68 11.51 
0.099 0.099 0.20 0.80 0.79 1.72 
0.099 0.098 0.81 0.90 0.88 2.19 
0.099 0.100 0.91 1.00 1.01 0.67 
0.099 0.100 1.02 1.17 1.09 7.29 
 
 
Figure 4.14 Ink titration results.  
(a) Comparison results between the fitted absorption coefficient (µa) and NIRS measured 
µa. (b) Comparison results between the fitted blood flow index (αDB) and DCS measured 
αDB. 
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Figure 4.15 Temperature variation results.  
(a) Comparison results between the fitted absorption coefficient (µa) and NIRS measured 
µa. (b) Comparison results between the fitted αDB and DCS measured αDB. 
 
 
Figure 4.16 Linear regressions of fitted unknowns against pre-set values.  
(a) Linear regression between the fitted µa and NIRS measured µa from ink titration tests. 
(b) Linear regression between the fitted blood flow index (αDB) and DCS measured αDB 
from temperature variation tests.  
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4.4 Discussion and conclusions 
We have developed an innovative scDCT system for BF imaging. Use of 
EMCCD/sCMOS camera as a 2D detection array significantly increases spatial 
resolution and speeds up data acquisition. Comparing to ncDCT that uses APDs as 
detector, the motion artifacts and lengthy scan time from mechanical scanning are 
mitigated with the novel design of scDCT. The optical zoom lens used in scDCT enabled 
adjustment of ROI with different sizes, thus offering translatability of the scDCT for 
small animals and large human subjects. The use of galvo mirror enabled flexible 
projection of source location to anywhere within FOV and made the source/detector 
pattern and scanning density adjustable for different applications.  
We have tested the scDCT system using tissue-simulating phantoms with two 
types of heterogeneities (high and low flow contrasts relative to the background). In both 
cases, flow contrast and anomaly geometries were successfully reconstructed. The 
recovered flow contrast changes in the cylindrical tube was highly correlated to the pump 
speed changes (R
2
 = 0.99, and p < 10
−5
) (Figure 4.9) demonstrating that we accurately 
captured the flow contrast/changes using scDCT. The recovered flow contrast of the 
solid sphere phantoms were 0.25 and 0.32 to the background (∼1.00) (Figure 4.10), 
which are comparable to our previous results found by similar phantoms [39, 44]. Their 
localization matched the actual arrangement in the phantom setup. Results from in vivo 
imaging on human forearm indicated the capability of scDCT on monitoring deep tissue 
blood flow distributions of both temporal and spatial variations. The hyperemic response 
after cuff occlusion was clearly visible at multiple locations in the forearm tissue (Figure 
4.11). The random spatial variation was expected due to regional tissue heterogeneities. 
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The pilot study on imaging of burn wounds demonstrates the feasibility of scDCT 
system for noncontact 3D imaging of blood flow distributions in vulnerable tissues with 
no risk of infection. As expected, significant lower BF values were observed in the 
burn/wound volumes compared with the surrounding unburn tissue volumes in both 
patients. Spatial heterogeneities in rBF were also observed across different tissue 
volumes (e.g., partial thickness burn versus full thickness burn) and over different 
depths. We noted that the rBF variation in Patient #2 (0.8 to 1.4) was larger than that in 
Patient #1 (0.9 to 1.2), generating a better rBF image contrast (Figure 4.13(b)). Thus, the 
rBF distribution from Patient #2 (Figure 4.13(b)) matched the pattern of the 
wound/eschar (Figure 4.13(a)) better than Patient #1 (Figure 4.12). The relatively 
smaller rBF variation/contrast across different tissue areas/volumes in Patient #1 made it 
more difficult to be detected. Also, it was possible that the “intact” tissue adjacent to the 
wound was affected by adjacent burn. Thus, it was not surprised that lower rBF 
areas/volumes were observed in the "intact" tissue adjacent to the "partial thickness 
burn" tissue (Figure 4.12). Due to the limited number of subjects in this study (n = 2), 
however, it is impossible to test the significance of inter-patient difference in rBF 
variations. More subjects are needed to test whether there is a minimum/maximum rBF 
variation that limits to clinical utility of the results. 
In addition to 3D reconstruction, 2D mapping of BF distributions has been 
establishedfor burned wounds. Similar patterns in BF contrasts were obtained comparing 
with 3D reconstruction. Comparing to 3D reconstructions which are time consuming 
(several hours), the 2D mapping (~3 min) is time efficient. The scDCT provides the 
depth resolution with the expense of computation time, whereas 2D mapping provides 
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real-time monitoring ability. Comparing to LSCI, 2D mapping with scDCT allows 
mapping of BF at different depths by selecting different S-D separations; larger S-D 
separations are, more weight from deeper layers. In summary, selection of 2D mapping 
and 3D reconstruction should be made upon specific applications. 
From the results of imaging burn wounds, although the trends of BF decreases in 
burn/wound areas agreed with surgeon’s prediction, the amplitudes of rBF decreases 
were smaller than expectated. This may be attributed to the influence of 𝜇𝑎 and 𝜇𝑠′ on 
αDB calculations, as discussed in Chapter 4.1 and Chapter 4.2.7 [25, 47, 106]. 
Therefore, we developed the new algorithm for extracting both 𝜇𝑎 and αDB.  
The new algorithm extracts μ𝑎 and αDB from the scDCT measurements without 
additional instrumentation or measurements. The assessment of 𝜇𝑎  improves the 
accuracy of αDB calculation from speckle contrast at multiple S-D separations. In 
previous studies, αDB was calculated with assumed 𝜇𝑎  or 𝜇𝑎  measured by other 
technique [44, 45, 110]. In this study, we eliminated the need of additional measurement. 
Moreover, knowledge of 𝜇𝑎 at multiple wavelengths provides the potential for tissue 
oxygenation measurements in the future. 
We have validated the new algorithm using tissue-like liquid phantoms with 
varied  μ𝑎 and αDB. Results measured by the new algorithm agreed well with those 
measured by DCS and NIRS over a wide range of  𝜇𝑎 and αDB which are commonly 
observed in biological tissues, indicating the potential of the algorithm for calculating 
both  𝜇𝑎 and αDB in a variety types of biological tissue. Promising results have been 
obtained especially in  𝜇𝑎 using light intensities at multiple S-D separations. Relatively 
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larger errors were found in αDB fitting when  𝜇𝑎 was large and SNR was low, indicating 
the sensitiveness of the new algorithm to SNRs.  
The next step is to apply this new algorithm for in vivo applications. One of the 
foreseen challenges is the tissue heterogeneity. Instead of using boundary data over the 
full FOV, we may select a subset data at a local/regional area for data fitting to reduce 
the influence of tissue heterogeneity. Other work to optimize the algorithm for in vivo 
applications include data screening, noise removal, and trade-off between data quality 
and time efficiency.   
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CHAPTER 5. STUDY SUMMARY, LIMITATIONS, AND FUTURE PERSPECTIVES 
 
5.1 Study Summary and my contributions 
In this dissertation, I presented the progression of advancing NIR diffuse optical 
techniques for spectroscopic measurements and tomographic imaging of tissue 
hemodynamics in vulnerable tissues with the goal of disease diagnosis and treatment 
monitoring. For the studies reported in Chapter 2, I participated in the adaptation and 
optimization of hybrid near infrared spectroscopy and diffuse correlation spectroscopy 
(NIRS/DCS) with a contact fiber-optic probe for simultaneous and continuous 
monitoring of absolute values of BF, blood oxygenation, and oxygen consumption in 
exercising gastrocnemius [28]. This is the first time that the hybrid NIRS/DCS 
techniques together with the novel occlusive calibration and gated dynamometer exercise 
protocol have been translated to lower limb measurement. My contributions include 
adaptation of the occlusive calibrations for absolute quantification of blood flow (BF) 
and oxygen consumption (VO2) in calf muscles, optimization of dynamometer gating 
exercise protocols and NIRS/DCS settings, validation tests in young healthy subjects, 
and characterization of muscle hemodynamic responses to exercise in older adults with 
vitamin D (vitD) insufficiency [38]. I conducted all optical measurements using a hybrid 
NIRS/DCS device in older population and analyzed all optical data. I also built an 
Arduino-based control system for real-time monitoring and recording of dynamometer 
foot pedal position and torque reading. I developed a MATLAB program with graphical 
user interface (GUI) for automatic torque peak recognition. Results from these 
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measurements indicated that vitD supplement plus aerobic training improved muscle 
metabolic function in older population [38].  
For the studies reported in Chapter 3, I adapted and optimized an innovative 
noncontact diffuse correlation spectroscopy and tomography (ncDCS/ncDCT) system for 
three dimensional (3D) imaging of mastectomy skin flaps and chronic wounds [39, 42, 
43, 101]. The ncDCS/ncDCT system employed optical lenses to project sources and 
detectors remotely onto the tissue surface which is appropriate for vulnerable tissue 
assessment comparing with contact apparatus as the noncontact measurement minimized 
the risk of inflammation. A motorized linear stage was employed to drive the noncontact 
probe to scan over a region of interests (ROI) for 3D tomographic imaging of blood flow 
distributions. The ncDCS/ncDCT system was applied in clinical applications, including 
intraoperative assessment of blood flow in mastectomy skin flaps [43] and in vivo 
imaging of chronic wounds. For intraoperative assessment of mastectomy skin flaps, I 
contributed to experimental design, data collection, and result interpretation. We found 
that intraoperative relative BF changes (rBF) immediately after mastectomy correlated 
with flap viability over months after the surgery, indicating the potential of ncDCS 
measurements for predicting skin flap necrosis. For imaging of chronic wounds, I 
independently established measurement protocol, performed optical measurements and 
data processing. Spatial variations in BF contrasts over the wounded tissues were 
observed, indicating the capability of ncDCT in detecting tissue hemodynamic 
heterogeneities. The ncDCT holds the potential for longitudinal monitoring and 
validation of chronic wound healing.  
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For the studies reported in Chapter 4, I adapted and optimized a novel camera-
based noncontact speckle contrast DCT (scDCT) for 2D/3D imaging of burn wounds 
[44, 45]. The scDCT employed a focused point source and a galvo mirror to remotely 
project point light onto source locations over a selected ROI. A camera with a flexible 
ROI and fast sampling rate was used for imaging of BF distributions. The camera 
provided 2D detector matrix thus eliminated the need for mechanical scanning and 
enabled fast data acquisition. Thousands of pixels provided by the camera significantly 
improve spatial resolution of imaging. I was involved in building and validating the 
scDCT system using tissue-simulating phantoms and in human forearms with a cuff 
occlusion protocol [45]. I upgraded the scDCT with a new scientific complementary 
metal–oxide–semiconductor (sCMOS) camera and optimized scDCT configuration to 
improve data quality. Finally, I adapted the scDCT for 3D imaging of burn wounds. I 
independently performed optical measurements and data processing, and wrote the 
manuscript [47]. Significantly lower BF values were observed in the burn areas 
compared to surrounding normal tissues. Due to the limited subject number, further 
interpretation of the measurement and its clinical utility are subject to future work. In 
addition to 3D reconstruction, I also explored fast 2D mapping of BF distributions 
towards real-time visualization. To overcome the influence of µa on BF quantification, I 
developed and validated a new algorithm to extract both µa and αDB using light 
intensities and speckle contrasts measured by scDCT at multiple source-detector 
distances [105, 106, 109-111]. The new algorithm enabled µa quantification and potential 
oxygenation assessment without adding additional measurement and improved the 
accuracy of αDB quantification using scDCT. I also designed and conducted phantom 
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validation tests for the new algorithm. In vivo application of the new algorithm is subject 
to future work.  
 
5.2 Study limitations and future perspectives 
Sample size and measurement validation. The sample sizes in the studies of 
imaging chronic wounds (n = 5) and burn wounds (n = 2) were small. In the future, more 
patients will be recruited, and results will be compared to other established techniques to 
verify the capability of noncontact scDCT for imaging of vulnerable tissues. We may 
also recruit and measure more patients with interventions; e.g., peripheral arterial disease 
(PAD) patients with ulcers under revascularization and cancer patients undergoing tissue 
flap reconstruction. We expect to correlate our measurement results with clinical 
outcomes for evaluation and prediction of intervention outcomes. 
Accuracy of BF quantification. Current data analyses for scDCT measurements 
(i.e., wound imaging) assumed constant 𝜇𝑎  from the literature [47]. This assumption 
many result in under- or over-estimation of rBF [25, 106]. Therefore, the new algorithm 
for extracting both µa and αDB from scDCT measurements has been developed in this 
dissertation work [106, 109, 111]. Future study will translate and optimize this 
innovative algorithm for in vivo applications to improve accuracy of BF quantification. 
Current scDCT system enables 3D imaging of BF distributions using one single 
wavelength. In the future, we may extend to a multi-wavelength system for simultaneous 
measurements of BF and oxygenation distributions for comprehensive assessment of 
tissue viability. 
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Time efficiency of image reconstruction. Depending on mesh density and 
boundary configurations, current algorithms for finite element method (FEM) based 3D 
image reconstruction requires several hours for computation, which is a big obstacle for 
intraoperative real-time monitoring. Recently, a fast and efficient sensitivity map 
generation method in NIRFAST for diffuse optical tomography (DOT) reconstruction 
has been developed [116]. This method employs a reduced sensitivity matrix and takes 
advantage of parallelization processes, thus reducing the computation burden and 
shortening the process time significantly. We may adapt this method to the modified 
NIRFAST for DCT reconstruction in the future to realize real-time imaging.  
Tissue geometry issue. For the patients with wounds imaged by our scDCT [47], 
DCT reconstructions were run with the assumption of a flat tissue surface geometry. Our 
previous studies showed that irregular tissue surface geometry can influence DCT 
reconstructions [46]. Very recently, we integrated a novel photometric stereo technique 
into the scDCT system to acquire both tissue surface geometry and boundary BFI data 
using the same camera [46]. We will adapt this method in future to improve the quality 
of image reconstructions.  
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APPENDIX: GLOSSARY 
Notations/terms Descriptions 
[Hb] deoxy-hemoglobin concentration  
[HbO2] oxy-hemoglobin concentration  
μa absorption coefficient  
µs’ reduced scattering coefficient  
2D two dimensional  
3D three dimensional  
αDB blood flow index (BFI) 
APD avalanche photodiode  
ASL-MRI arterial-spin-labeled magnetic resonance imaging  
AT aerobic training  
AUC area under the ROC curve  
BF blood flow  
CTL control 
CW continuous-wave 
D vitD repletion alone  
DAT vitD repletion + aerobic training  
DCS diffuse correlation spectroscopy 
DCT diffuse correlation tomography 
DOT diffuse optical tomography 
EMCCD electron-multiplying charge coupled device 
FD frequency domain (FD) 
FEM finite element method (FEM) 
FOV field of view (FOV) 
fps frame per second (fps) 
GUI graphical user interface (GUI) 
H2O water  
Hb deoxy-hemoglobin 
HbO2 oxy-hemoglobin  
I light intensity 
IRB Institutional Review Board (IRB) 
λ wavelength 
𝑘0 wavenumber  
𝐾 speckle contrast 
LCD liquid crystal display (LCD) 
LDF laser Doppler flowmetry (LDF) 
MRI magnetic resonance imaging (MRI) 
MVC maximal voluntary isometric contractions (MVC) 
ncDCS noncontact diffuse correlation spectroscopy 
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ncDCT noncontact diffuse correlation tomography  
NIR near-infrared light (NIR） 
NIRS Near-infrared spectroscopy (NIRS) 
PAD peripheral arterial disease  
PET Positron emission tomography  
P-MRS phosphorus magnetic resonance spectroscopy  
rBF Relative changes in blood flow 
ROC receiver operating characteristic 
ROI region of interest  
rVO2 relative change in oxygen consumption 
scDCT speckle contrast DCT  
sCMOS scientific complementary metal–oxide–semiconductor 
SD secure digital 
S-D source-detector  
SEM standard error of mean  
SNR signal-to-noise ratio  
StO2 blood oxygenation saturation 
τ correlation delay time 
T Exposure time 
T50 recovery half-time 
THC total hemoglobin concentration  
UK University of Kentucky  
vitD Vitamin D  
VO2 oxygen consumption rate  
WCC Wound Care Clinic  
ΔStO2 change of blood oxygenation saturation  
 
 
 
 
 
REFERENCES 
1. A. D. Jaskille et al., "Critical review of burn depth assessment techniques: part II. Review 
of laser doppler technology," J Burn Care Res 31(1), 151-157 (2010). 
2. M. Augustin, and K. Maier, "Psychosomatic aspects of chronic wounds," Dermatology 
and Psychosomatics/Dermatologie und Psychosomatik 4(1), 5-13 (2003). 
3. K. Moreo, "Understanding and overcoming the challenges of effective case management 
for patients with chronic wounds," Case Manager 16(2), 62-63, 67 (2005). 
4. C. A. Salzberg et al., "A new pressure ulcer risk assessment scale for individuals with 
spinal cord injury," Am J Phys Med Rehabil 75(2), 96-104 (1996). 
5. N. Bergstrom et al., "The Braden Scale for Predicting Pressure Sore Risk," Nurs Res 
36(4), 205-210 (1987). 
6. H. R. Moyer, and A. Losken, "Predicting mastectomy skin flap necrosis with indocyanine 
green angiography: the gray area defined," Plast Reconstr Surg 129(5), 1043-1048 
(2012). 
7. Q. Luu, and D. G. Farwell, "Advances in free flap monitoring: have we gone too far?," 
Curr Opin Otolaryngol Head Neck Surg 17(4), 267-269 (2009). 
8. D. D. Adler et al., "Doppler ultrasound color flow imaging in the study of breast cancer: 
preliminary findings," Ultrasound Med Biol 16(6), 553-559 (1990). 
9. I. V. Larina et al., "Hemodynamic measurements from individual blood cells in early 
mammalian embryos with Doppler swept source OCT," Opt Lett 34(7), 986-988 (2009). 
10. S. Hu, and L. V. Wang, "Photoacoustic imaging and characterization of the 
microvasculature," Journal of biomedical optics 15(1), 011101 (2010). 
11. H. M. Subhash et al., "Volumetric in vivo imaging of microvascular perfusion within the 
intact cochlea in mice using ultra-high sensitive optical microangiography," IEEE Trans 
Med Imaging 30(2), 224-230 (2011). 
12. T. Yamada et al., "Clinical reliability and utility of skin perfusion pressure measurement 
in ischemic limbs--comparison with other noninvasive diagnostic methods," J Vasc Surg 
47(2), 318-323 (2008). 
13. B. T. Phillips et al., "Intraoperative perfusion techniques can accurately predict 
mastectomy skin flap necrosis in breast reconstruction: results of a prospective trial," 
Plast Reconstr Surg 129(5), 778e-788e (2012). 
14. R. Singer et al., "Fluorescein test for prediction of flap viability during breast 
reconstructions," Plast Reconstr Surg 61(3), 371-375 (1978). 
15. R. Benya, J. Quintana, and B. Brundage, "Adverse reactions to indocyanine green: a case 
report and a review of the literature," Cathet Cardiovasc Diagn 17(4), 231-233 (1989). 
16. A. Nouvong et al., "Evaluation of diabetic foot ulcer healing with hyperspectral imaging 
of oxyhemoglobin and deoxyhemoglobin," Diabetes Care 32(11), 2056-2061 (2009). 
100 
 
17. R. D. Braun et al., "Comparison of tumor and normal tissue oxygen tension 
measurements using OxyLite or microelectrodes in rodents," Am J Physiol Heart Circ 
Physiol 280(6), H2533-2544 (2001). 
18. C. R. Wyss et al., "Transcutaneous oxygen tension measurements on limbs of diabetic 
and nondiabetic patients with peripheral vascular disease," Surgery 95(3), 339-346 
(1984). 
19. O. U. Scremin et al., "Preamputation evaluation of lower-limb skeletal muscle perfusion 
with H(2) (15)O positron emission tomography," Am J Phys Med Rehabil 89(6), 473-486 
(2010). 
20. M. P. Francescato, and V. Cettolo, "Two-pedal ergometer for in vivo MRS studies of 
human calf muscles," Magn Reson Med 46(5), 1000-1005 (2001). 
21. V. Ntziachristos et al., "Concurrent MRI and diffuse optical tomography of breast after 
indocyanine green enhancement," Proc Natl Acad Sci U S A 97(6), 2767-2772 (2000). 
22. J. P. Culver et al., "Diffuse optical tomography of cerebral blood flow, oxygenation, and 
metabolism in rat during focal ischemia," J Cereb Blood Flow Metab 23(8), 911-924 
(2003). 
23. H. Liu et al., "Determination of optical properties and blood oxygenation in tissue using 
continuous NIR light," Phys Med Biol 40(11), 1983-1993 (1995). 
24. M. N. Kim et al., "Noninvasive measurement of cerebral blood flow and blood 
oxygenation using near-infrared and diffuse correlation spectroscopies in critically brain-
injured adults," Neurocrit Care 12(2), 173-180 (2010). 
25. D. Irwin et al., "Influences of tissue absorption and scattering on diffuse correlation 
spectroscopy blood flow measurements," Biomed Opt Express 2(7), 1969-1985 (2011). 
26. K. Gurley, Y. Shang, and G. Yu, "Noninvasive optical quantification of absolute blood 
flow, blood oxygenation, and oxygen consumption rate in exercising skeletal muscle," 
Journal of biomedical optics 17(7), 075010 (2012). 
27. Y. Shang et al., "Noninvasive optical characterization of muscle blood flow, oxygenation, 
and metabolism in women with fibromyalgia," Arthritis research & therapy 14(6), R236 
(2012). 
28. B. Henry et al., "Hybrid diffuse optical techniques for continuous hemodynamic 
measurement in gastrocnemius during plantar flexion exercise," Journal of biomedical 
optics 20(12), 125006 (2015). 
29. D. Boas, T. Gaudette, and S. Arridge, "Simultaneous imaging and optode calibration with 
diffuse optical tomography," Opt Express 8(5), 263-270 (2001). 
30. R. J. Cooper et al., "Transient haemodynamic events in neurologically compromised 
infants: a simultaneous EEG and diffuse optical imaging study," Neuroimage 55(4), 
1610-1616 (2011). 
31. R. A. De Blasi et al., "Cerebral and muscle oxygen saturation measurement by frequency-
domain near-infra-red spectrometer," Med Biol Eng Comput 33(2), 228-230 (1995). 
101 
 
32. G. Yu et al., "Noninvasive monitoring of murine tumor blood flow during and after 
photodynamic therapy provides early assessment of therapeutic efficacy," Clin Cancer 
Res 11(9), 3543-3552 (2005). 
33. T. Durduran et al., "Diffuse optical measurement of blood flow, blood oxygenation, and 
metabolism in a human brain during sensorimotor cortex activation," Opt Lett 29(15), 
1766-1768 (2004). 
34. G. Yu et al., "Validation of diffuse correlation spectroscopy for muscle blood flow with 
concurrent arterial spin labeled perfusion MRI," Opt Express 15(3), 1064-1075 (2007). 
35. C. Zhou et al., "Diffuse optical correlation tomography of cerebral blood flow during 
cortical spreading depression in rat brain," Opt Express 14(3), 1125-1144 (2006). 
36. D. A. Boas, and A. G. Yodh, "Spatially varying dynamical properties of turbid media 
probed with diffusing temporal light correlation," JOSA A 14(1), 192-215 (1997). 
37. Y. Shang et al., "Effects of muscle fiber motion on diffuse correlation spectroscopy blood 
flow measurements during exercise," Biomed Opt Express 1(2), 500-511 (2010). 
38. D. T. Thomas et al., "Local In Vivo Measures of Muscle Lipid and Oxygen Consumption 
Change in Response to Combined Vitamin D Repletion and Aerobic Training in Older 
Adults," Nutrients 11(4), (2019). 
39. Y. Lin et al., "Three-dimensional flow contrast imaging of deep tissue using noncontact 
diffuse correlation tomography," Appl Phys Lett 104(12), 121103 (2014). 
40. C. Huang et al., "Alignment of sources and detectors on breast surface for noncontact 
diffuse correlation tomography of breast tumors," Appl Opt 54(29), 8808-8816 (2015). 
41. L. He et al., "Noncontact diffuse correlation tomography of human breast tumor," 
Journal of biomedical optics 20(8), 86003 (2015). 
42. C. Huang et al., "Noncontact diffuse optical assessment of blood flow changes in head 
and neck free tissue transfer flaps," Journal of biomedical optics 20(7), 075008 (2015). 
43. N. B. Agochukwu et al., "A Novel Noncontact Diffuse Correlation Spectroscopy Device 
for Assessing Blood Flow in Mastectomy Skin Flaps: A Prospective Study in Patients 
Undergoing Prosthesis-Based Reconstruction," Plast Reconstr Surg 140(1), 26-31 (2017). 
44. C. Huang et al., "Speckle contrast diffuse correlation tomography of complex turbid 
medium flow," Medical physics 42(7), 4000-4006 (2015). 
45. C. Huang et al., "Noncontact 3-D Speckle Contrast Diffuse Correlation Tomography of 
Tissue Blood Flow Distribution," IEEE Trans Med Imaging 36(10), 2068-2076 (2017). 
46. S. Mazdeyasna et al., "Noncontact speckle contrast diffuse correlation tomography of 
blood flow distributions in tissues with arbitrary geometries," Journal of biomedical 
optics 23(9), 1-9 (2018). 
47. M. Zhao et al., "Noncontact Speckle Contrast Diffuse Correlation Tomography of Blood 
Flow Distributions in Burn Wounds," 2018 MHSRS Supplement to the Journal of 
Military Medicine (under revision) (2019). 
102 
 
48. T. Hamaoka et al., "The use of muscle near-infrared spectroscopy in sport, health and 
medical sciences: recent developments," Philos Trans A Math Phys Eng Sci 369(1955), 
4591-4604 (2011). 
49. J. L. Jasperse, D. R. Seals, and R. Callister, "Active forearm blood flow adjustments to 
handgrip exercise in young and older healthy men," J Physiol 474(2), 353-360 (1994). 
50. B. Chance et al., "Recovery from exercise-induced desaturation in the quadriceps 
muscles of elite competitive rowers," Am J Physiol 262(3 Pt 1), C766-775 (1992). 
51. V. Quaresima, R. Lepanto, and M. Ferrari, "The use of near infrared spectroscopy in 
sports medicine," J Sports Med Phys Fitness 43(1), 1-13 (2003). 
52. U. Wolf et al., "Localized irregularities in hemoglobin flow and oxygenation in calf 
muscle in patients with peripheral vascular disease detected with near-infrared 
spectrophotometry," J Vasc Surg 37(5), 1017-1026 (2003). 
53. A. Elvin et al., "Decreased muscle blood flow in fibromyalgia patients during 
standardised muscle exercise: a contrast media enhanced colour Doppler study," Eur J 
Pain 10(2), 137-144 (2006). 
54. R. Zelis et al., "A comparison of regional blood flow and oxygen utilization during 
dynamic forearm exercise in normal subjects and patients with congestive heart failure," 
Circulation 50(1), 137-143 (1974). 
55. K. K. McCully, C. Halber, and J. D. Posner, "Exercise-induced changes in oxygen 
saturation in the calf muscles of elderly subjects with peripheral vascular disease," J 
Gerontol 49(3), B128-134 (1994). 
56. G. Yu et al., "Time-dependent blood flow and oxygenation in human skeletal muscles 
measured with noninvasive near-infrared diffuse optical spectroscopies," Journal of 
biomedical optics 10(2), 024027 (2005). 
57. A. Sinha et al., "Improving the vitamin D status of vitamin D deficient adults is 
associated with improved mitochondrial oxidative function in skeletal muscle," J Clin 
Endocrinol Metab 98(3), E509-513 (2013). 
58. Z. C. Ryan et al., "1alpha,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen 
Consumption and Dynamics in Human Skeletal Muscle Cells," J Biol Chem 291(3), 
1514-1528 (2016). 
59. S. McMahon, and H. A. Wenger, "The relationship between aerobic fitness and both 
power output and subsequent recovery during maximal intermittent exercise," J Sci Med 
Sport 1(4), 219-227 (1998). 
60. D. T. Ubbink et al., "Skin microcirculation in diabetic and non-diabetic patients at 
different stages of lower limb ischaemia," Eur J Vasc Surg 7(6), 659-656 (1993). 
61. E. Wahlberg et al., "Level of arterial obstruction in patients with peripheral arterial 
occlusive disease (PAOD) determined by laser Doppler fluxmetry," Eur J Vasc Surg 
7(6), 684-689 (1993). 
103 
 
62. Z. Chen et al., "Optical Doppler tomography: imaging in vivo blood flow dynamics 
following pharmacological intervention and photodynamic therapy," Photochem 
Photobiol 67(1), 56-60 (1998). 
63. J. C. Baron, "Mapping the ischaemic penumbra with PET: implications for acute stroke 
treatment," Cerebrovasc Dis 9(4), 193-201 (1999). 
64. P. Schmitt et al., "Quantitative tissue perfusion measurements in head and neck 
carcinoma patients before and during radiation therapy with a non-invasive MR imaging 
spin-labeling technique," Radiother Oncol 67(1), 27-34 (2003). 
65. R. F. Mottram, "The oxygen consumption of human skeletal muscle in vivo," J Physiol 
128(2), 268-276 (1955). 
66. M. N. Smithies et al., "Comparison of oxygen consumption measurements: indirect 
calorimetry versus the reversed Fick method," Crit Care Med 19(11), 1401-1406 (1991). 
67. T. Sako et al., "Validity of NIR spectroscopy for quantitatively measuring muscle 
oxidative metabolic rate in exercise," J Appl Physiol (1985) 90(1), 338-344 (2001). 
68. Y. Shang et al., "Diffuse optical monitoring of repeated cerebral ischemia in mice," Opt 
Express 19(21), 20301-20315 (2011). 
69. Y. Shang et al., "Cerebral monitoring during carotid endarterectomy using near-infrared 
diffuse optical spectroscopies and electroencephalogram," Phys Med Biol 56(10), 3015-
3032 (2011). 
70. G. Yu, "Near-infrared diffuse correlation spectroscopy in cancer diagnosis and therapy 
monitoring," Journal of biomedical optics 17(1), 010901 (2012). 
71. R. Cheng et al., "Near-infrared diffuse optical monitoring of cerebral blood flow and 
oxygenation for the prediction of vasovagal syncope," Journal of biomedical optics 
19(1), 17001 (2014). 
72. Y. Shang et al., "Portable optical tissue flow oximeter based on diffuse correlation 
spectroscopy," Opt Lett 34(22), 3556-3558 (2009). 
73. H. M. Kooijman et al., "Near infrared spectroscopy for noninvasive assessment of 
claudication," J Surg Res 72(1), 1-7 (1997). 
74. E. Selvin, and T. P. Erlinger, "Prevalence of and risk factors for peripheral arterial 
disease in the United States: results from the National Health and Nutrition Examination 
Survey, 1999-2000," Circulation 110(6), 738-743 (2004). 
75. A. Yodh, and B. Chance, "Spectroscopy and imaging with diffusing light," Physics 
Today 48(3), 34-41 (1995). 
76. B. Chance, "Optical Tomography, photon migration, and spectroscopy of tissue and 
model media-theory, human studies and instrumentation," Proc. SPIE (1995). 
77. R. M. Danen et al., "Regional imager for low-resolution functional imaging of the brain 
with diffusing near-infrared light," Photochem Photobiol 67(1), 33-40 (1998). 
78. D. A. Boas, "Diffuse photon probes of structural and dynamical properties of turbid 
media: theory and biomedical applications," Citeseer (1996). 
104 
 
79. C. Cheung et al., "In vivo cerebrovascular measurement combining diffuse near-infrared 
absorption and correlation spectroscopies," Phys Med Biol 46(8), 2053-2065 (2001). 
80. A. Kienle, and M. S. Patterson, "Improved solutions of the steady-state and the time-
resolved diffusion equations for reflectance from a semi-infinite turbid medium," J Opt 
Soc Am A Opt Image Sci Vis 14(1), 246-254 (1997). 
81. M. S. Patterson et al., "Absorption spectroscopy in tissue-simulating materials: a 
theoretical and experimental study of photon paths," Appl Opt 34(1), 22-30 (1995). 
82. L. Dong et al., "Diffuse optical measurements of head and neck tumor hemodynamics for 
early prediction of chemoradiation therapy outcomes," Journal of biomedical optics 
21(8), 85004 (2016). 
83. D. M. Hueber et al., "New optical probe designs for absolute (self-calibrating) NIR tissue 
hemoglobin measurements," Optical tomography and spectroscopy of tissue III 618-632 
(1999). 
84. S. Fantini, M. A. Franceschini, and E. Gratton, "Semi-infinite-geometry boundary 
problem for light migration in highly scattering media: a frequency-domain study in the 
diffusion approximation," JOSA B 11(10), 2128-2138 (1994). 
85. S. L. Jacques, "Optical properties of biological tissues: a review," Phys Med Biol 58(11), 
R37-61 (2013). 
86. D. T. Delpy et al., "Estimation of optical pathlength through tissue from direct time of 
flight measurement," Phys Med Biol 33(12), 1433-1442 (1988). 
87. D. R. White, H. Q. Woodard, and S. M. Hammond, "Average soft-tissue and bone 
models for use in radiation dosimetry," Br J Radiol 60(717), 907-913 (1987). 
88. D. R. White et al., "The composition of body tissues (II). Fetus to young adult," Br J 
Radiol 64(758), 149-159 (1991). 
89. D. A. Boas, L. Campbell, and A. G. Yodh, "Scattering and imaging with diffusing 
temporal field correlations," Physical review letters 75(9), 1855 (1995). 
90. S. O. Rice, "Mathematical analysis of random noise," Bell System Technical Journal 
24(1), 46-156 (1945). 
91. A. Einstein, "On the motion of small particles suspended in liquids at rest required by the 
molecular-kinetic theory of heat," Annalen der physik 17(549-560 (1905). 
92. R. A. De Blasi et al., "Noninvasive measurement of human forearm oxygen consumption 
by near infrared spectroscopy," Eur J Appl Physiol Occup Physiol 67(1), 20-25 (1993). 
93. Y. Shang, K. Gurley, and G. Yu, "Diffuse Correlation Spectroscopy (DCS) for 
Assessment of Tissue Blood Flow in Skeletal Muscle: Recent Progress," Anat Physiol 
3(2), 128 (2013). 
94. S. Zetterquist, "The effect of active training on the nutritive blood flow in exercising 
ischemic legs," Scand J Clin Lab Invest 25(1), 101-111 (1970). 
95. T. A. Mustoe, K. O'Shaughnessy, and O. Kloeters, "Chronic wound pathogenesis and 
current treatment strategies: a unifying hypothesis," Plast Reconstr Surg 117(7 Suppl), 
35S-41S (2006). 
105 
 
96. T. Mustoe, "Understanding chronic wounds: a unifying hypothesis on their pathogenesis 
and implications for therapy," Am J Surg 187(5A), 65S-70S (2004). 
97. H. Brem et al., "Evidence-based protocol for diabetic foot ulcers," Plast Reconstr Surg 
117(7 Suppl), 193S-209S; discussion 210S-211S (2006). 
98. A. J. Boulton, "The diabetic foot: from art to science. The 18th Camillo Golgi lecture," 
Diabetologia 47(8), 1343-1353 (2004). 
99. G. C. Leng et al., "Incidence, natural history and cardiovascular events in symptomatic 
and asymptomatic peripheral arterial disease in the general population," Int J Epidemiol 
25(6), 1172-1181 (1996). 
100. E. Tukiainen, F. Biancari, and M. Lepantalo, "Lower limb revascularization and free flap 
transfer for major ischemic tissue loss," World J Surg 24(12), 1531-1536 (2000). 
101. T. Li et al., "Simultaneous measurement of deep tissue blood flow and oxygenation using 
noncontact diffuse correlation spectroscopy flow-oximeter," Sci Rep 3(1358 (2013). 
102. H. Dehghani et al., "Near infrared optical tomography using NIRFAST: Algorithm for 
numerical model and image reconstruction," Commun Numer Methods Eng 25(6), 711-
732 (2008). 
103. R. C. Allam, "Micronized, particulate dermal matrix to manage a non-healing pressure 
ulcer with undermined wound edges: a case report," Ostomy Wound Manage 53(4), 78-82 
(2007). 
104. R. P. Boezeman et al., "Monitoring of Foot Oxygenation with Near-infrared 
Spectroscopy in Patients with Critical Limb Ischemia Undergoing Percutaneous 
Transluminal Angioplasty: A Pilot Study," Eur J Vasc Endovasc Surg 52(5), 650-656 
(2016). 
105. A. M. Chiarelli et al., "Low-resolution mapping of the effective attenuation coefficient of 
the human head: a multidistance approach applied to high-density optical recordings," 
Neurophotonics 4(2), 021103 (2017). 
106. L. Dong et al., "Simultaneously extracting multiple parameters via fitting one single 
autocorrelation function curve in diffuse correlation spectroscopy," IEEE Trans Biomed 
Eng 60(2), 361-368 (2013). 
107. B. Chance et al., "Effects of solutes on optical properties of biological materials: models, 
cells, and tissues," Anal Biochem 227(2), 351-362 (1995). 
108. D. Tamborini et al., "Development and characterization of a multidistance and 
multiwavelength diffuse correlation spectroscopy system," Neurophotonics 5(1), 011015 
(2018). 
109. J. Liu et al., "Simultaneously extracting multiple parameters via multi-distance and multi-
exposure diffuse speckle contrast analysis," Biomed Opt Express 8(10), 4537-4550 
(2017). 
110. C. P. Valdes et al., "Speckle contrast optical spectroscopy, a non-invasive, diffuse optical 
method for measuring microvascular blood flow in tissue," Biomed Opt Express 5(8), 
2769-2784 (2014). 
106 
 
111. P. Farzam, and T. Durduran, "Multidistance diffuse correlation spectroscopy for 
simultaneous estimation of blood flow index and optical properties," Journal of 
biomedical optics 20(5), 55001 (2015). 
112. C. Jiang et al., "Dedicated hardware processor and corresponding system-on-chip design 
for real-time laser speckle imaging," Journal of biomedical optics 16(11), 116008 (2011). 
113. A. K. Dunn, "Laser speckle contrast imaging of cerebral blood flow," Ann Biomed Eng 
40(2), 367-377 (2012). 
114. A. Rajaram et al., "Simultaneous monitoring of cerebral perfusion and cytochrome c 
oxidase by combining broadband near-infrared spectroscopy and diffuse correlation 
spectroscopy," Biomed Opt Express 9(6), 2588-2603 (2018). 
115. D. A. Boas, and A. K. Dunn, "Laser speckle contrast imaging in biomedical optics," 
Journal of biomedical optics 15(1), 011109 (2010). 
116. X. Wu et al., "Fast and efficient image reconstruction for high density diffuse optical 
imaging of the human brain," Biomed Opt Express 6(11), 4567-4584 (2015). 
 
 
 
 
VITA 
Mingjun Zhao, PhD candidate 
EDUCATION 
Biomedical Engineering, PhD program, University of Kentucky (UKY), US      2012/08 -- 2019/07            
Date of qualifying exam: 12/16/2014; GPA: 3.69/4.0  
Biomedical Engineering, B.E, Tianjin University (TJU), China                   2008/09 -- /2012/07 
 
PROFESSIONAL POSITIONS  
Research Assistant, Department of Biomedical Engineering, UKY, Lexington, KY 
 
 
AWARDS & HONORS 
2017 fall      Max Steckler Fellowship  
2014 /04       Conference Travel Support Awards, UKY  
2011/10      1st Prize of 5th National Competition of MEMS Application, China  
 
PROFESSIONAL MEMBERSHIP  
2014, 2018 Optical Society of America (OSA)        
2017, 2018 Biomedical Engineering Society (BMES) 
 
PEER-REVIEWED JOURNAL PUBLICATIONS 
1. M. Zhao, S. Mazdeyasna, C. Huang, N. B. Agochukwu, A. Bonaroti, L. Wong, G. Yu, 
"Noncontact Speckle Contrast Diffuse Correlation Tomography of Blood Flow Distributions 
in Burn Wounds", 2018 MHSRS Supplement to the Journal of Military Medicine (Under 
revision) 
2. D. T. Thomas; D. Schnell; M. Redzic; M. Zhao; H. Abraha; D. Jones; H. Brim; G. Yu. 
“Local in vivo measures of muscle lipid and oxygen consumption change in response to 
combined vitamin D repletion and aerobic training in older adults”, Nutrients, 11(4), 930 
(2019) 
3. S. Mazdeyasna, C. Huang, M. Zhao, N. B. Agochukwu, A. A. Bahrani, L. Wong, G. Yu, 
“Noncontact speckle contrast diffuse correlation tomography of blood flow distributions in 
tissues with arbitrary geometries”, Journal of Biomedical Optics, 23(9), 096005 (2018) 
4. C. Huang, D. Irwin, M. Zhao, Y. Shang, N. B. Agochukwu, L. Wong, G. Yu, “Noncontact 3-
dimensional speckle contrast diffuse correlation tomography of tissue blood flow 
distribution”, IEEE Transactions on Medical Imaging, 36(10), 2017 
108 
 
5. N. B. Agochukwu*, C. Huang*, M. Zhao, A. Bahrani, L. Wong, G. Yu, “A novel noncontact 
diffuse correlation spectroscopy for assessing blood flow in mastectomy skin flaps: a 
prospective study in patients undergoing prosthesis-based reconstruction”, Plastic and 
Reconstructive Surgery, 140(1), 2017. *Contributed equally. 
6. B. Henry*, M. Zhao*, Y. Shang, T. Uhl, D. T. Thomas, E. S. Xenos, S. P. Saha, G. Yu, 
“Hybrid diffuse optical techniques for continuous hemodynamic measurement in 
gastrocnemius during plantar flexion exercise”, Journal of Biomedical Optics, 20(12), 125006 
(2015). *Contributed equally. 
 
CONFERENCE PROCEEDINGS/ABSTRACTS 
1. S. Mazdeyasna, A. Bonaroti, C. Huang, M. Zhao, M. Mohtasebi, X. Liu, L. Wong, G. Yu, 
“Noninvasive 3D Optical Imaging of Blood Flow Distributions in Mastectomy Skin 
Flaps”, BMES Annual Scientific Meeting, Philadelphia, PA (Submitted, 2019) 
2. S. Mazdeyasna, C. Huang, M. Zhao, A. Bonaroti, L. Wong, G. Yu, “Noninvasive 3D Optical 
Imaging of Blood Flow Distributions in Mastectomy Skin Flaps”, UK Markey Cancer 
Research Day, Lexington, KY, 2019 
3. M. Mohtasebi, A. Bahrani, M. Zhao, G. Yu, “Simultaneous Measurements of Cerebral Blood 
Oxygenation and Metabolism using Noninvasive Near-infrared Spectroscopy”, UK CCTS 
Spring Conference, Lexington, KY, 2019 
4. M. Zhao, C. Huang, G. Yu, “Extracting Multiple Tissue Optical Properties from Speckle 
Contrast Diffuse Correlation Tomography (scDCT) Measurements”, UK CCTS Spring 
Conference, Lexington, KY, 2019 
5. S. Mazdeyasna, C. Huang, M. Zhao, M. Mohtasebi, A. Bonaroti, L. Wong, G. Yu, 
“Noncontact 2D and 3D diffuse optical imaging of tissue blood flow distributions”, UK 
CCTS Spring Conference, Lexington, KY, 2019 
6. M. Zhao, D. Jones, D. T. Thomas, G. Yu, “Monitoring of Muscle Hemodynamics during 
Exercise Using Hybrid Near-infrared Spectroscopy and Diffuse Correlation Spectroscopy in 
Older Adults”, BMES Annual Scientific Meeting, Atlanta, GA, 2018 
7. S. Mazdeyasna, C. Huang, M. Zhao, N. Agochukwu, A. Bahrani, L. Wong, G. Yu, 
“Intraoperative 3D imaging of blood flow distributions in mastectomy skin flaps using 
noncontact speckle contrast diffuse correlation tomography”, BMES Annual Scientific 
Meeting, Atlanta, GA, 2018  
8. L. Wong, M. Zhao, C. Huang, N. Agochukwu, S. Mazdeyasna, A. Bahrani, L. Chen, J. 
Radabaugh, R. Aouad, G. Yu, “Perioperative Optical Assessment of Blood Flow Variations 
in Soft Tissues: Implications for Assessment & Management of Battlefield Injuries”, Military 
Health System Research Symposium, Kissimee, FL, (2018)   
9. M. Zhao, C. Huang, N. Agochukwu, L. Wong,
 
J. P. Radabaugh, R. K. Aouad, G. Yu, 
“Intraoperative Monitoring of Tissue Blood Flow Alterations for Predicting Flap Necrosis”, 
UK Markey Cancer Research Day, Lexington, KY, 2018  
10. M. Zhao, C. Huang, S. Mazdeyasna, N. Agochukwu, L. Wong, G. Yu, “Noncontact Speckle 
Contrast Diffuse Correlation Tomography for 3-D Blood Flow Imaging of Burn Wounds”,  
UK CCTS Spring Conference, Lexington, KY, 2018 
11. D. Jones, M. Zhao, G. Yu, D. T. Thomas, “Vitamin D Repletion Coupled with Aerobic 
Training Improves Skeletal Muscle Oxygen Extraction During Fatiguing Exercise in Healthy 
Older Adults”, UK CCTS Spring Conference, Lexington, KY, 2018 
109 
 
12. S. Mazdeyasna, C. Huang, M. Zhao, A. Bahrani, N. Agochukwu, L. Wong, G. Yu, 
“Intraoperative imaging of blood flow distributions in mastectomy skin flaps using speckle 
contrast diffuse correlation tomography”,  UK CCTS Spring Conference, Lexington, KY, 
2018 
13. D. Irwin, C. Huang, M. Zhao, S. Mazdeyasna, A. Bahrani, G. Yu, “Noncontact Imaging of 
Flow and Fluorescence Contrasts”, UK CCTS Spring Conference, Lexington, KY, 2018 
14. M. Zhao, C. Huang, D. Irwin, S. Mazdeyasna, A. Bahrani, N. Agochukwu, L. Wong. G. Yu, 
“EMCCD-based Speckle Contrast Diffuse Correlation Tomography of Tissue Blood Flow 
Distribution”. Biophotonics Congress: Biomedical Optics, Hollywood, FL, 2018. Oral 
Presentation 
15. M. Zhao, C. Huang, L. Chen, J. Radabaugh, R. Aouad, N. Agochukwu, L. Wong, G. Yu, 
“Intraoperative Assessment of Blood Flow Variations in Tissue Flaps Using Noncontact 
Diffuse Correlation Spectroscopy”. Biophotonics Congress: Biomedical Optics, Hollywood, 
FL, 2018. Oral Presentation 
16. M. Zhao, C. Huang, S. Mazdeyasna, E. A. Jawdeh, H. Bada, G. Yu, “A Novel Fiberless 
Diffuse Speckle Contrast Flowmeter for Tissue Blood Flow Measurement”. Biophotonics 
Congress: Biomedical Optics, Hollywood, FL, 2018. Oral Presentation 
17. N. Agochukwu, C. Huang, S. Mazdeyasna, M. Zhao, G. Yu, L. Wong. “3D Imaging of 
Tissue Blood Flow in Mastectomy Skin Flaps”. American Society of Plastic Surgeons 2017 
Annual Meeting. Oral Presentation. 
18. S. Mazdeyasna, C. Huang, N. McGregor, M. Zhao, A. Bahrani, G. Yu, “A photometric stereo 
technique to acquire tissue surface geometry for 3D imaging of blood flow distributions in 
mastectomy skin flaps”, BMES Annual Scientific Meeting, Phoenix, AZ, 2017 
19. S. Mazdeyasna, C. Huang, M. Seong, J. Morgan, M. Zhao, A. Bahrani, J. Kim, J. Hastings, 
G. Yu, “A novel low-cost compact diffuse speckle contrast flowmeter for contact blood flow 
measurement”, BMES Annual Scientific Meeting, Phoenix, AZ, 2017 (oral presentation). 
20. M. Zhao, C. Huang, D. Irwin, S. Mazdeyasna, N. Agochukwu, L. Wong, G. Yu, “Noncontact 
3-dimensional speckle contrast diffuse correlation tomography of tissue blood flow 
distribution”, BMES Annual Scientific Meeting, Phoenix, AZ, 2017 (oral presentation) 
21. M. Zhao, C. Huang, N. Agochukwu, A. Bahrani, S. Mazdeyasna, L. Wong, G. 
Yu, Noncontact diffuse correlation spectroscopy assessment of tissue blood flow for the 
prediction of mastectomy skin flap necrosis”, BMES Annual Scientific Meeting, Phoenix, 
AZ, 2017 
22. M. Zhao, C. Huang, N. Agochukwu, L. Wong, G. Yu, “Noncontact diffuse optical 
assessment of blood flow imaging in mastectomy skin flaps”, UK CCTS Spring Conference, 
Lexington, KY, 2017 
23. M. Zhao, C. Huang, N. Agochukwu, L. Wong, G. Yu, “Noncontact Diffuse Optical Imaging 
of Blood Flow Distribution and Necrosis Prediction in Mastectomy Skin Flaps”, Markey 
Cancer Center Breast Cancer Symposium, Lexington, KY, 2017 
24. C. Huang, M. Zhao, D. Irwin, N. Agochukwu, L. Wong, G. Yu, “Noncontact 3-dimensional 
speckle contrast diffuse correlation tomography of tissue blood flow distribution”, UK CCTS 
Spring Conference, Lexington, KY, 2017 (Oral) 
25. C. Huang, M. Zhao, D. Irwin, N. Agochukwu, L. Wong, G. Yu, “Noncontact 3-dimensional 
speckle contrast diffuse correlation tomography of tissue blood flow distribution”, Markey 
Cancer Center Breast Cancer Symposium, Lexington, KY, 2017 
26. N. B. Agochukwu, C. Huang, M. Zhao, G. Yu, L. Wong, “A novel noncontact optical 
110 
 
method for assessing blood flow in mastectomy skin flaps: A prospective study in patients 
undergoing prosthetic based reconstruction”. Annual Meeting of the Southeastern Society of 
Plastic Surgeons, Orlando FL, (2016) (oral presentation) 
27. G. Yu, C. Huang, N. B. Agochukwu, M. Zhao, L. Wong, “Intraoperative optical assessment 
of blood flow changes in mastectomy skin flaps in patients with breast cancer”, Markey 
Cancer Center Breast Cancer Symposium, Lexington, KY, 2016 (Oral) 
28. C. Huang, N. B. Agochukwu, M. Zhao, “L. Wong, G. Yu, Intraoperative optical assessment 
of blood flow changes in mastectomy skin flaps”, UK CCTS Spring Conference, Lexington, 
KY, 2016 
29. M. Zhao, C. Huang, E. Xenos, G. Yu, “Diffuse Optical Assessment of Blood Flow 
Distribution in Wounded Tissue: A Case Study”, UK CCTS Spring Conference, Lexington, 
KY, 2015 
30. M. Zhao, Y. Shang, B. Henry, T. L. Uhl, G. Yu, “Tissue metabolic rate of oxygen 
consumption in calf muscle measured by arterial and venous occlusion protocols”, OSA 
Biomedical Optics (BIOMED), Miami, FL, 2014 
31. M. Zhao, Y. Shang, B. A. Henry, G. Yu, “Measurements of tissue metabolic rate of oxygen 
consumption in skeletal muscle using arterial and venous occlusion protocols”, University of 
Kentucky Muscle Biology Fall Retreat, Lexington, KY, 2013 
32. B. A. Henry, Y. Shang, M. Zhao, T. Uhl, and G. Yu, “Diffuse optical spectroscopies for 
continuous monitoring of absolute tissue hemodynamics in calf muscle during plantar flexion 
exercise”, University of Kentucky Muscle Biology Fall Retreat, Lexington, KY, 2013 
33. M. Zhao, Y. Shang, B. A. Henry, G. Yu, “Measurements of tissue metabolic rate of oxygen 
consumption in skeletal muscle using arterial and venous occlusion protocols”, University of 
Kentucky Muscle Biology Fall Retreat, Lexington, KY, 2013 
34. D. Irwin, Y. Lin, L. He, C. Huang, Y. Shang, M. Zhao, G. Yu, “Noncontact 3-D imaging of 
small animal tumors with combined diffuse optical, correlation, and fluorescence 
tomography: preliminary results in phantoms”, UK CCTS Spring Conference, Lexington, 
KY, 2013 
35. M. Zhao, Y. Shang, B. A. Henry, G. Yu, “Comparison of ultrasound imaging and skinfold 
caliper measurements of subcutaneous adipose tissue thickness”, UK CCTS Spring 
Conference, Lexington, KY, 2013 
36. D. Irwin, Y. Lin, L. He, C. Huang, Y. Shang, M. Zhao, G. Yu, “Noncontact 3-D imaging of 
small animal tumors with combined diffuse optical, correlation, and fluorescence 
tomography: preliminary results in phantoms”, UK Markey Cancer Research Day, Lexington, 
KY, 2013 
 
 
 
